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Abstract
Systems biology is a field of increasing importance in biology research. It aims to study
the functioning of inter- and intra-cellular dynamic networks, using signal- and system-
oriented approaches. In this thesis, we apply this idea to investigate the regulatory roles
of microRNAs.
MicroRNAs are small non-coding RNAs, which inhibit the gene expression by bind-
ing to the target genes. Mounting evidence shows that microRNAs are involved in many
crucial biological processes, including cancer. Among them, one critical process—p53-
dependent apoptosis pathway—is selected to accommodate microRNA to conduct the
study. During the investigation, we solve the core problem step by step.
First of all, the surrounding network about the well-known protein p53 is investi-
gated. Ordinary differential equations are built to describe the underlying mechanisms.
Based on the mathematical model, two novel phenomena are predicted to describe the
stability change and frequency shift due to the varying levels of external stimulus. Ex-
periment guidelines to validate these predictions are also provided accordingly.
Secondly, we employ a discrete formalism—Petri net—to model a large-scale net-
work, p53-dependent apoptosis pathway. One challenge in systems biology is how to
obtain an accurate and predictable computational model for the biomolecular networks
under study. Therefore, to enhance the reliability, we propose two approaches to check
the model’s correctness, which are based on invariant analysis and reachability analysis,
respectively. The case studies show good competency of those approaches.
Thirdly, we tackle the core problem about microRNA. The prediction of microRNAs’
targets presents a big obstacle in microRNA studies. Because bioinformatics tools offer
enormous targets, most of which are believed to be false positive. Model checking based
method is developed to address this issue. MicroRNA and its targets are put into p53-
dependent apoptosis pathways. Then, the validity of the predicted targets is determined
by the comparisons between models with and without considering microRNA’s inhibition
on respective targets. The experimental evidence provides the evaluation criteria. In
case of lacking evidence, experimental design schemes are provided based on the desired
specifications as well.
In summary, in this thesis, we illustrate the whole procedure to investigate the
regulatory role of microRNAs by addressing the problem of microRNA target validation.
In addition, the approach developed here may finally evolve into a formal method to
comprehensively and rapidly validate target mRNAs for the microRNA, which may help
us to understand cancer better and design new therapeutic strategies for cancer.
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Since DNA was deciphered, molecular biology has been experiencing a fast pace of
evolvement. The biologists were constantly trying to make it clear that life is made of
chemistry and physics. They believed that once we had found the smallest component of
life, we would be able to have a thorough understanding of life. Accordingly, molecular
biology had been developed to identify and characterize the individual gene or protein [2].
Unfortunately, the interactions among components are always neglected, which produces
an incomplete picture and thus hinder the understanding of the organism as a whole.
The shortcomings of the aforementioned component-based research have led to a
revival of holistic approaches. Moreover, the conventional experimentation is strongly
dependent on the experience of the biologists and is usually performed in a trial-and-
error manner, which is time-consuming, labour-intensive and inefficient. The biology
society urges the revolution of methodologies and in recent years have seen more and
more research activities in the field of systems biology.
1.1 Systems Biology
Systems biology is concerned with the dynamics of biochemical reaction networks
within cells and in cell population, using signal- and system-oriented approaches, thereby
1.1 Systems Biology
observing the behaviours at the system level [48]. Systems biology is an emerging
area of research, which is truly inter-disciplinary, as it combines various disciplines and
areas of research, such as life science, systems engineering, mathematical modelling and
simulation, computer science, statistics, etc.
Systems biology in the biological revolution is closely associated with the fields of
“genomics, transcriptomics, proteomics and metabolomics” [109]. With the emergence
of these fields, molecular biology shifts its focus from molecular characterization to the
understanding of functional activities. For example, in the past, single gene was studied,
whereas with DNA microarray technology we can now measure the activity levels of
thousands of genes simultaneously. Thus, it is possible to identify inter-relationships
between groups of genes and analyse dynamic interactions among these genes.
As we can see, all the above interactions are the consequences of dynamics and
controlled processes. Therefore, it is not surprising to apply systems theory to biological
systems. However, this work is not a routine application of control methods and systems
theory to an unconventional plant. The most appreciated work of systems biology is to
be conducted by closely cooperating with the biologists. It is necessary to learn their
demands and requirements before collecting the data from the collaborators and the
biological literatures. Moreover, the engineering solutions must be meaningful to their
implementations and understandable to the biologists, as opposed to some impractical
ideas.
The development of experimental and measurement techniques makes systems bi-
ology urgent. New technologies, such as modern microscopy, laser tweezers, nanotech-
nology, as well as DNA microarrays, and mass spectrometry accelerate the generation
of data. It becomes apparent that the methodological advances in data analysis are
urgently required [47]. We must convert the newly available data into information and
knowledge. Therefore, how to manage these data is as important as the technological
development. Currently, we may apply a variety of systems biology methods to handle
the complexity of biological systems. As the discoveries of molecular biology pave the
2
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way for system structure, one motivation for systems biology is to bring these static
diagrams to life by modelling and simulating the biochemical reactions that underlie
cell functions, development and diseases.
Figure 1.1 shows an interactive workflow that we follow to apply systems biology
methods. From the discoveries of science and initial experimentation, we are able to
learn the basic mechanisms of the biological system. Together with the measured data,
we can build some preliminary computational models to generate simulation results. To
increase the reliability of the model, we ought to perform iterative model verifications.
When the model is robust enough, we may use this model to propose hypotheses. This
will help the biologists to judiciously design the experiments and further discover more
insightful facts.
Figure 1.1: Systems Biology Workflow Diagram [108]
1.2 Motivation and Purpose
Bearing this philosophy in mind, we conduct the systems biology research in a problem-
driven manner. The initiatives start from the potential facilities and solutions to the
3
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problems in biology society. In this part, I will introduce our motivation and purpose
of the research topics in this thesis.
MicroRNA, usually of length of 20 nt, can repress the genes’ expression and accelerate
or decelerate the formation of cancer cells. Therefore, the discovery of this tiny RNA is
expected to bring revolutionary means to cancer treatment [9]. However, the regulatory
roles of microRNAs remain to be elucidated. One main problem for microRNA is to
identify the repressed targets [56]. However, one microRNA can regulate a great number
of target genes, usually in the scale of hundreds. To make things more intricate, one
gene could be regulated by several microRNAs. The bioinformatic tools could predict the
targets based on base-pairing principles [87]. However, the screening of whole genome
gives too many targets to be considered as true [56]. The only thing that biologists can
do is to validate these targets in the way of trial-and-error one by one. With the validated
targets, some well-known pathways where the roles of microRNAs are included could
be re-evaluated accordingly. For example, in [1], the roles of E2F and Myc in cancer
pathways are studied by including the regulation by mir-17-92.
Our motivation in this topic is to develop a formal method to predict the highly possi-
ble targets out of the results from bioinformatics tools. Then, the shortlisted candidates
are provided to the biologists to save the time and labour-cost. Meanwhile, mounting
evidence shows that microRNAs are involved in many crucial biological processes to
regulate the tumorigenesis. Among them, we select one critical process—p53-dependent
apoptosis pathway where the role of microRNAs is investigated. Then, we develop our
methods for the core problem step by step. To the best of our knowledge, this is the
first time to validate the targets of microRNAs in the context of dynamical pathways
using the systems biology approach.
First of all, the networks surrounding the well known protein p53 is investigated.
The protein p53 lies at the centre of several critical pathways in our body. It correlates
with cell cycle, cell death, angiogenesis, etc [99]. When the cell is stressed by oncogenic
stimuli, p53 will prevent the progression of malignancy in the involved pathways. The
4
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main role of p53 is the transcriptional activation of the target genes which then join the
downstream pathways to exert the corresponding repressive functions. Among the target
genes, Mdm2 influences the p53 level negatively in return. Thus, the feedback makes
the p53 level oscillate [7]. This phenomenon has been observed in the wet lab and drawn
much attention of the modellers. To deeply investigate the p53-Mdm2 core regulation,
we build our own model to reproduce the oscillation and the model itself facilitates
further analyses and predictions. Many results have not been discovered before, and
could provide potential evidence to explore this core regulation. For example, the level
of the stimulating agent has two thresholds which govern the occurrence of oscillation.
The first threshold is reported by the literatures, whereas the second one has not been
reported before. Moreover, from the simulation results, we find the frequency drift with
respect to the agent level. This phenomenon is also ignored by the previous work. We
predict this frequency shifting and provide the practical operation guideline to assist the
validation experimentation. The verification of these two new phenomena could be fed
back to the modelling work and improve the credibility of our model.
Next, we move to a large-scale network—p53-dependent apoptosis pathway. In the
aforementioned modelling work, it is built by non-linear ordinary differential equations
in continuous-time domain. The core regulation contains a small number of players,
thereby avoiding many troubles on the parameter identifications. Manual tuning is suf-
ficient. However, in p53-dependent apoptosis pathway, there are dozens, even hundreds
of players and the related parameters which generate an insurmountable gap [40]. To
address this problem, we adopt the formalisms in discrete domain to emphasize more
on the structure information and qualitative properties. In this work, we choose Petri
net as one ideal candidate due to its natural affinity to represent the species and re-
actions under its framework. Accordingly, model validation is an immediate task to
guarantee the model’s correctness. We analyse the mathematical description of Petri
net and provide two alternative ways to tackle this. Invariant and reachability analysis
are obtained from the characteristics of state equations. The solutions both efficiently
5
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verify the structure information of the model.
Succeeding the discrete modelling of p53-dependent apoptosis pathway, we continue
the investigation of our core topic—microRNA. MicroRNAs exert their functions to in-
hibit the gene expression by binding to the target genes [9]. To deal with the target vali-
dation problem, we still work on the discrete model and borrow the model-checking tech-
nique from computer science to explore the solutions. Since the well-established model
could be interpreted in many different perspectives, in this work, we put microRNA at
the locations of its targets which are involved in the p53-dependent apoptosis pathways,
and investigate the influences. The proposed method compares the behaviours of the
model with the real evidence. Based on the differences, we may conclude the validity of
these targets.
As can be seen, we start from the biological problems and formulate into a manage-
able mathematics and engineering problem. We develop our approaches from multiple
disciplines, such as mathematics, engineering, computer science, physics, bioinformatics,
etc. We hope that the provided solutions could finally benefit the biology society and
facilitate their verification and subsequent discoveries.
1.3 Organization of Thesis
In the following three chapters, we discuss our main research topics of the p53-Mdm2
core regulations, apoptosis pathway modelling and validation and microRNA targets,
respectively. Each chapter will begin with the introduction of biological objectives,
then followed by the technical backgrounds. The methods are illustrated by solving the
concerned problems or the representative examples. Discussion and conclusion sections
are presented to summarize each chapter.
Finally, Chapter 5 concludes the whole thesis and propose the future directions which
extend current work.
Besides, Appendix C is employed to introduce the background knowledge about
biology and experimental methods. Basic biological concepts, such as cell, nucleus,
6
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DNA, protein, central dogma of molecular biology, gene expression, are introduced to
help understanding our research objectives. Moreover, some popular experimental tools
are primarily surveyed. Both introductions will facilitate the interpretation of the results




As described in Section 1.2, we initiate our research by investigating the p53 protein.
P53 is a well-known tumour suppressor with many anticancer mechanisms. The protein
itself has drawn intensive attention in biology research. It can activate apoptosis, the
programmed cell death in which microRNAs is also believed to influence the biomolecular
regulations. Therefore, it is our first step to explore the activities around this protein.
2.1 Introduction
2.1.1 P53
The p53 tumour suppressor lies at the centre of cellular pathways that sense DNA dam-
age, cellular stress and oncogenetic stimulation [99]. P53 integrates such signals and,
in response, induces growth arrest, triggers apoptosis (programmed cell death), blocks
angiogenesis or mediates DNA repair, etc. [35] The critical role of p53 is experimentally
evidenced by the presence of mutations found in almost 50% human tumours. There-
fore, studies of p53 have attracted attentions of many researchers in life science for
decades [15].
P53 serves as a transcriptional activator to promote the target genes’ expressions
and the downstream products will repair the double-strand breaks (DSB) and ulti-
2.1 Introduction
mately mitigate the DNA damage [27]. The structure of human p53 protein is shown in
Figure 2.1. DNA binding site is used for targeting the genes. MDM2 TA site is bound
by Mdm2, inducing the degradation of p53. When the cell is stressed by DNA damage
signal or other stimuli, some agents will change the formation of p53 through phospho-
rylation and acetylation on the N and C-terminal, respectively. For instance, ATM’s
phosphorylation will enhance the binding ability of p53 to target gene, and meanwhile,
it will weaken the binding ability of Mdm2 to p53 because ATM will add a phosphotate
group at ser 15, which is inside the Mdm2 site.
Figure 2.1: The structure of human p53 protein [27].
2.1.2 P53-Mdm2 Core Regulation
The p53 network is normally “off”. In normal cells, p53 protein usually maintains
at a low level and has a short half-life due to the degradation by ubiquitination and
proteolysis. The inhibitor is Mdm2 protein which is a E3 ubiquitin ligase for p53 and
also a target gene of p53 simultaneously. Apparently, there exists a negative feedback
to maintain the low p53 level. The core regulation can be simply represented as p53→
Mdm2 a p53. Furthermore, the Mdm2-interacting region in p53 resides at the 1-42
9
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amino acids within N-terminal region. On the other hand, when the cell is stressed by
DNA damage signal, such as ultraviolet (UV), ionizing radiation (IR), ATM will add
phosphate group to the serine 15 which leads to the poor binding ability of Mdm2 to p53.
Thus the p53 level will be raised and activated to perform its major functions. Besides,
ATM has another role to accelerate the transcription of target genes by phosphorylation
of p53 [5]. All the above introductions can be summarized in Figure 2.2.
Figure 2.2: Schematic diagram to illustrate p53-Mdm2 core regulation. Arrow represents
activation, while arrow-bar means inhibition. IR is short for ionizing radiation. τ is the
assumed time lag from p53 to Mdm2’s translation.
Recently, two research groups found the oscillation phenomena in p53-Mdm2 loop [7,
52]. The capture by western blot from [7] is shown in Figure 2.3. Damped oscillatory
behaviours in population of cells and undamped oscillatory behaviours in individual
cells were observed after the irradiation. Oscillatory expressions are actually observed
in many other systems, such as Hes1 and NF-κB related networks [66, 70, 83]. Due
to the lack of biological evidence and experimental data, the true mechanisms are not
illustrated yet. Therefore, these oscillations motivate researchers’ interest in the study
of p53-Mdm2 core regulation; and many investigations have been devoted to build a
reasonable model to qualitatively explain this oscillatory phenomenon.
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Figure 2.3: P53-Mdm2 oscillation observation after ionizing radiation from [7]. A is
from Mouse fibroblasts NIH 3T3 cells and B is from Human breast cancer epithelial
MCF-7 cells.
2.1.3 Objective
In this chapter, the main objective is to investigate the p53-Mdm2 regulation in both
time and frequency domains so as to obtain more insights on the regulatory mechanisms
and propose verifiable hypotheses. First of all, a new mathematical model, which falls
into the category of delayed feedback, is proposed by taking ATM’s dual role into ac-
count. ATM is involved to associate the DNA damage signal with this core regulation,
which is expressed by a simple dynamics in the model. Next, using this converter, bi-
furcation analysis of p53 with respect to ionizing radiation is performed; consequently, a
threshold mechanism of radiation dose, which has never been discussed before, is found.
Moreover, variation of p53-Mdm2 oscillation frequency is usually ignored in the existing
literature. Inspired by this, we investigate frequency shifting phenomenon by Fourier
frequency analysis on the model. Accordingly, we facilitate the experiment design by
an optimized guideline. Bifurcation and frequency analysis are both contributing to the
experimental validation and design in practice.
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The rest parts are organized as follows. The modelling principle by mass action
law is firstly introduced in Section 2.2. In Section 2.3, mathematical expressions are
derived one by one according to the biological bases and assumptions. Next, simulation
results and bifurcation analyses are given to exploit the model. In Section 2.5, through
Fourier frequency analysis, a design scheme is provided to help conducting the wet lab
experiments. Discussion part is dedicated to advise experimental verifications for model
predictions. Finally, this chapter ends with the conclusion part.
2.2 Mass Action Law Based Modelling
When we want to determine the reaction kinetics, we have to evaluate the reaction
rates for a product or reactant in a particular reaction: the amount(in numbers or
concentrations) per unit time that is formed or removed. It is named as “Mass Action
Law” [105]. The basic assumption is collision theory, i.e. the reaction can be triggered
by the collision of two reactants. And the reaction rate is proportional to the probability
of collision of the reactants.
For example, there is a bimolecular reversible reaction.
S1 + S2 
k1k2 2P








= k1[S1][S2]− k2[P ]2
The bracketed variables [S1], [S2]and[P ] denote the time-varying amount of interest,
concentrations or molecular numbers. k1, k2 are called rate constant, which depends
on temperature, pH-value, pressure, etc., while time-independent. Thus, given the en-
vironment keeps invariant, the reaction rate will depend only on the concentration or
numbers.
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Most biochemical reactions will be catalysed by huge numbers of enzymes. So the
catalytical reactions exist universally in cells. “Michaelis-Menten Kinetics” describes
the rate of enzyme-mediated reactions based on mass action law.
The reaction equation is as follows:
E + S 
k1k−1 C(ES)→k2 E + P
It has a reversible formation of the enzyme-substrate complex ES and an irreversible
release of the product P from the complex.
Use mass action law to model each reaction.
d[S]
dt
= −k1[E][S] + k−1[ES]
d[ES]
dt
= k1[E][S]− (k−1 + k2)[ES]
d[E]
dt




A key assumption here is the quasi steady-state approximation, namely that the
concentration of the complex change much more slowly than the substrate and product.
d[ES]
dt
= 0 = k1[E][S]− (k−1 + k2)[ES]
,which can be rearranged to [ES] = k1[E][S]k−1+k2 .








Based on conservation law, we will have
[E0] = [E] + [ES] (2.2)
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As can be found, Km is an indicator of the affinity that an enzyme has for a given
substrate and hence the stability of the enzyme-substrate complex. Furthermore, when
substrate concentration [S] is equal to Km, the reaction rate is half of the maximal
rate Vmax, which is approximately got from the large enough [S]. At low [S], it is the
availability of substrate that is the limiting factor. As more substrate is added, there
will be a rapid increase in the initial rate of the reaction. The relationship between the
reaction rate against substrate concentration [S] is shown in Figure 2.4.
2.3 Modelling and Simulation Results
The existing modelling works about p53-Mdm2 core regulation are all in continuous
domain. It has been learned that oscillations can arise from negative feedback alone,
which is composed of at least three components [97]. Hence, in Lev Bar-Or’s work [7],
they resorted to a putative intermediary in the negative feedback loop. They explored
the dependence of oscillations on different parameters, such as kdelay, which represents
the time lag from intermediary to Mdm2. This inspired other research efforts which
considered this time lag as an explicit parameter in the transcriptional and translational
process of Mdm2. One of the representative studies was done by Monk in [66], where he
proposed a delayed feedback model and integrated all the time lags as one explicit term
14
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Figure 2.4: Michaelis-Menten Kinetics. [S] axis is drawn in logarithmic-scale.
in the formation process of Mdm2. From then on, most researchers have adopted this
idea for modelling the p53-Mdm2 regulation, such as [100, 14]. In particular, Wagner
and his co-workers took a significant step in investigating the global dynamics under
different parameter bifurcations in [100]. An alternative approach was suggested in [23]
by Tyson and his colleagues via introducing a positive feedback mechanism besides the
common negative feedback loop, without relying on the explicit time delay.
Another remarkable work from Alon’s research group gave a long-term (up to 3 days)
experimental data set in [33]. Moreover, they summarized six different model types for
the dynamics of p53-Mdm2 network. They built a stochastic model concerning about
the variability between cells as well. Other studies from a stochastic point of view were
done in [62, 18]. Most recently, Ramalingam and his colleagues collected the experi-
mental data using protein lysate microarrays [77]. Then based on the observations, they
identified the parameters of the mathematical model adopted from [7, 62]. Subsequently,
they knocked out p53 gene in silico by setting the production rate as zero. Finally, they
made a good verification by the real experiment in vivo.
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Our model relies on prevailing evidence and widely accepted assumptions. For the
sake of simplicity, only the p53 and Mdm2 proteins are considered, rather than the
messenger RNAs of them. The reliability of this simplification will be verified by the
later simulation results. The delays happened in the transcription, translation and
translocation processes are all merged as one delay term appearing explicitly in the
Mdm2 dynamics. The selections of parameters are performed after scaling the original
equations.
2.3.1 Model
First of all, p53 dynamics is evaluated as
dp53
dt
= ap − dp × p53− deg(S(t))× p53
p53 +Kp
×Mdm2. (2.5)
Here the first term ap specifies the synthesis rate of the p53 protein; the second term
reflects the Mdm2-independent p53 degradation, while dp is the basal degradation rate;
the last term describes the Mdm2-induced p53 degradation. Michaelis-Menten kinetics
is applied to this process, consistent with an enzyme (Mdm2)-catalyzed degradation
from a substrate (p53 protein). As for deg(S(t)), it is the degradation rate which is a
function of ATM, denoted by S(t).
The expression for deg(S(t)) is




where d0 is the basal rate for Mdm2-dependent p53 degradation. As shown in [5] ,
when the cell is exposed to the ionizing radiation, ATM can weaken the binding ability
of Mdm2 to p53. So this basal degradation rate will be reduced by the existence of
ATM. It is assumed that the reduction follows a Hill function with order, also called
cooperativity, n.
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Secondly, the dynamics of Mdm2 is described in the following equation,
dMdm2
dt




where the coefficients am and dm give the basal rate of synthesis and degradation for
Mdm2, respectively. The last term represents the transcription activation of Mdm2 by
p53. Here transcription product—Mdm2 messenger RNA—is replaced by Mdm2 protein
and phosphorylated p53 is replaced by p53 protein. The two forms of p53 will not be
discriminated in this model. The phosphorylation by ATM kinase is expressed in the
coefficient function agg(S(t)). To account for p53’s preference for tetramerisation [102],
P2 promoter’s dependence on p53 is modeled as a Hill function with cooperativity 4.
Time lag τ is utilized to represent all the duration cost in this process.
The function agg(S(t)) is formulated as




Finally, the connection from stress signal to the core regulation via ATM’s kinetics
comprises the following two first-order dynamics.
dS
dt






× (IR− dam). (2.10)
Eq.(2.9) shows the ATM’s dependence on the DNA damage denoted by dam, in which
the second term describes the degradation of ATM. Eq.(2.10) describes damage gener-
ated due to ionizing radiation IR, i.e. the input to the whole system. On the other
hand, when the stress signal is withdrawn, it is assumed that the repair of DNA damage
will follow the process below.
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2.3.2 Selection of Parameters












































Here, we use dimensionless scaling to help reducing the burden for selection of pa-
rameters, which is a common method in systems modelling [100, 1]. Thus, the rescaled
dynamics is expressed by the new variables in the following form.
d ˆp53
dtˆ












(tˆ− τˆ) + Kˆm4
dSˆ
dtˆ











× dam, when stress signal is withdrawn
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To highlight the role of p53 in transcriptional activation, aˆ0 should be selected much
greater than 1, which is the unitized basal synthesis rate of Mdm2. The same selection
criterion is applicable to the p53’s degradation rates. Mdm2 makes the p53’s proteolysis
much faster compared with the basal degradation. Hence dˆ0 is reasonably considered
much greater than dˆp. In most existing literatures, the basal synthesis rate of Mdm2 and
degradation rate of p53 are neglected. As for the Hill function’s cooperativity, orders of
1 and 4 in Eq.(2.5) and Eq.(2.7) are selected according to the Michaelis-Menten kinetics
and p53’s tetramerisation. The orders of n and m used in Eq.(2.6) and Eq.(2.8) are
determined by the sensitivity of the components. Moreover, the time delay τ is a key
factor for the existence of oscillation [73]. For example, the values below a critical point
τ0 = 0.875 will eliminate the oscillation when IR is set as 0.5 in this model. The rest
selection of parameters are based on literatures [7, 66, 100] and manual tuning.
Summarizing above, all the parameters are listed in Table 2.1. In the following, we
omit the hat accent from the variables and parameters in the scaled equations and use
P and M as abbreviations of p53 and Mdm2 respectively, as these changes do not cause
misunderstandings.
Table 2.1: Parameter list of dimensionless kinetics equations
Parameter Value Parameter Value
dˆp 0.2 dˆ0 2
Kˆp 0.2 Kˆ1 0.3
aˆ0 4
Kˆm 0.5 Kˆ2 0.2
m 2 n 2
τˆ 1 dˆs 1
Tˆ1 2 Tˆ2 100
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2.3.3 Simulation Result
Our model exhibits sustained oscillation in response to increased radiation dose. As
can be seen in Figure 2.5, during the interval 0 ≤ t ≤ 15, the cell stays under normal
condition without exposure to ionizing radiation (IR = 0). p53 is maintained at low
level due to the spontaneous inhibition by Mdm2. After t > 15, the cell is exposed
to ionizing radiation (IR = 0.5). The oscillation persists until ionizing radiation is
withdrawn at t = 100. Then the p53 and Mdm2 both return to the original states
through a transient process, which consists of damped oscillations. It will be seen that
the levels of p53 and Mdm2 differ much, which is due to the scaling operation. However,
we will focus on the qualitative behavior rather than the quantitatively accurate time
and concentration information in this work.




















Figure 2.5: Temporal performance of p53 and Mdm2. During 15 ≤ t ≤ 100, IR = 0.5.
In other durations, IR = 0. Other parameters are listed in Table 2.1.
The first peak of p53 is earlier than Mdm2 after onset of IR, and the lag is about 1.8.
The periods for both variables are the same. These performances fit to the experimental
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data in [7, 52] and previous simulation results. The difference resides on the scale, which
is due to the parameters’ selections. The evolvement also agrees with the observed
experimental phenomenon.
After performing simulations under different dose levels, it is observed that the
oscillation period is changing, although it is not very obvious in the time domain of
simulation results using current parameter set. This interesting variation inspires the
detailed frequency analysis discussed in Section 2.5.
As evidenced by the experimental data shown in Figure 6b of [7], weak damage
signal will slow the rise of steady state and no observable oscillations exist within the
time frame of the experiment. To verify this point, IR is reduced to 0.2, and the result
depicted in Figure 2.6 shows that the oscillation disappears and settling time is elongated
compared to the previous case.




















Figure 2.6: Temporal performance of p53 and Mdm2. During 15 ≤ t ≤ 100, IR = 0.2.




According to the simulation results above, during the sustained oscillation interval, when
IR = 0.2, p53 stays at a stable steady state. When IR is raised to 0.5, p53 will oscillate,
meaning that the original fixed point changes its stability. Moreover, if IR is considered
as a parameter, it will induce the bifurcation of the nonlinear systems expressed by
Eq.(2.5)–(2.10). Specifically, this is Hopf Bifurcation, i.e. the stable equilibrium point
becomes unstable by a parameter change, and a limit cycle appears in the neighbourhood
[94].
Eq.(2.9) and (2.10) show the independence of S and dam on the p53 and Mdm2
dynamics. The solutions of S(t) and dam(t) are shown as








The settling times depend on the parameter ds and T1.
Meanwhile, given ds = 1 and T1 = 2, let
dS
dt






× (IR− dam∗) = 0
then get the steady-state equality S∗ = dam∗ = IR, where asterisk denotes the steady
state. Therefore, in the given parameter set, the variables S and dam get equal to input
IR fast.
Thus, it is convenient to study the bifurcation of reduced systems, which is comprised
of only p53 and Mdm2 kinetics. Let the right hand sides of scaled p53 and Mdm2
equations equal zero and replace S with S∗ = IR.
1− dp × P ∗ − deg(IR)× P
∗
P ∗ +Kp
×M∗ = 0 (2.12)
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After arrangement, by using the same parameter set above, an implicit function of
P ∗ with the parameter IR is derived below.











P ∗4 + 0.54
]
= 0 (2.14)
According to Descarte’s rule of sign [49], it is assured to have real positive solution.
Because of the high order existing in the implicit function, it is hard to get a close-
form solution of P ∗. By sampling IR’s range [0.1, 0.3] by interval of 0.02, we perform
symbolic solver in Matlab iteratively. Several pairs of coordinates can be obtained. The
negative real roots and complex roots are filtered because of the reality consideration.
When IR = 0.2, the steady state of p53 is approximately 0.277, the same as shown in
Figure 2.6, which can also be seen in bifurcation diagram shown in Figure 2.7.














Figure 2.7: Bifurcation diagram of p53’s steady state with respect to IR. For the stable
limit cycle, the maxima and minima are drawn. When IR is greater than 20, the steady
state converges to 5. Data are not shown here.
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According to the bifurcation diagram, when IR > 0.32, the oscillation happens.
When IR > 0.56, the oscillation disappears and returns to the unique steady state again.
Theoretically, it is because ATM’s level also becomes bigger when IR is sufficiently
large. p53’s degradation by Mdm2’s ubiquitination is largely inhibited by ATM. That’s
to say, the third term of Eq.(2.5) can be neglected. Consequently, p53 level will be
definitely raised, and Mdm2 is also aggregating due to the transcriptional activation by
p53, leading the level higher than the basal level. Thus, p53 and Mdm2 will not be
influenced by the ATM as much as in the oscillation region, and the core regulation is
modified by the elimination of Mdm2’s inhibition on p53. An example can be seen in
Figure 2.8. So far, there are no experimental data showing the response of big dose
of ionizing radiation. The analysis based on this model predicts the retrieval of stable
steady states at higher level.






















Figure 2.8: Temporal performance of p53 and Mdm2. During 15 ≤ t ≤ 80, IR = 0.8.
In other durations, IR = 0. Other parameters are listed in Table 2.1.
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2.5 Frequency Analysis and Experiment Design
The numerical simulations suggest the changes of p53-Mdm2 oscillation periods with
respect to the level of IR. This is a very interesting phenomenon and has never been
discussed from simulations of the core regulation to the best of the authors’ knowledge.
In the time domain, the changes of periods are hard to be detected given the existence
of noises, which motivate us to consider this issue in the frequency domain. In the
frequency spectrum, the dominant frequencies due to oscillations will appear as pulses,
which can be distinguished from noise. However, the direct validation of this predicted
frequency shifting phenomenon requires accurate measurements of the p53 and Mdm2
concentrations at a very high sampling rate, say 10 times measurements per hour. This
seems to be an unreasonable expectation for the current wet lab experiment techniques.
To address this issue, we turn to frequency domain analysis, in particular Discrete
Fourier Transform(DFT) and Fast Fourier Transform(FFT) [74]. The main purpose of
frequency domain analysis is to determine the frequency at which p53 oscillates when
the value of IR changes at a relatively lower requirement for the data measurements.
Another advantage of dealing with the experiment design in the frequency domain is
that the original frequency of the oscillation can be perfectly reconstructed in theory
with limited sampled data. Based on Fourier analysis, the sampling frequency and total
sample points required for proper design of experiment can be selected such that in
practice, the original time series on p53 concentration can be reconstructed perfectly
from the sampled data points.
2.5.1 Frequency Domain Analysis
Our first task here is to determine the frequency of the p53-Mdm2 oscillations under a
specified IR level from our numerical simulation, which is called a predicted frequency.
This is achieved through doing DFT on the simulated time series data and analysing it
in the frequency domain.
To obtain the DFT of the time series of p53 concentration, Fast Fourier Transform
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(FFT) is performed on the simulation result in Matlab. The IR value is set to be non-
zero for the whole simulation interval as only the region where sustained oscillations
occur is of interest. The time domain simulation result under this setting is given in
Figure 2.9. Then, the first one-third of the time series obtained is truncated before
the FFT so that only the oscillations with constant amplitude are considered. Besides,
the solution given by numeric solver is not equally spaced in time, so it is needed to
interpolate the solution and re-sample it at a regular interval before performing FFT.
This will make sure that the signal is a valid input for the FFT routine [81].
Based on Nyquist sampling theorem, the sampling frequency is chosen as 1, which is
much more than twice the different dominant frequencies (results shown later). Another
parameter to be considered here is the number of sample points N . N is chosen to be
as large as possible so that the frequency determined from DFT is more accurate.




















Figure 2.9: Time domain simulation result with oscillation for whole time interval,
IR = 0.5
The amplitude spectrum of the DFT of the time series of p53 concentration when
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IR is set to 0.5 is shown in Figure 2.10. There are two prominent peaks observed at
F = 0 and F = 0.1996. The peak at F = 0 arises because there is a DC offset in
the waveform. The peak at F = 0.1996 gives the dominant frequency of oscillation.
The process was repeated for IR in oscillatory range [0.32, 0.56]. The frequencies of
oscillation corresponding to different radiation doses are shown in Table 2.2.


















Figure 2.10: Amplitude spectrum of DFT of p53 concentration when IR = 0.5
Table 2.2: Normalized frequencies of oscillations for different IR values
IR Frequency IR Frequency
0.33 0.2133 0.45 0.2045
0.36 0.2114 0.48 0.2016
0.39 0.2094 0.51 0.1986
0.42 0.2065 0.55 0.1937
From the spectral analysis, simulated results show that the maximum frequency of
oscillation is 0.2133, which occurs at IR = 0.33. The minimum frequency of oscillation
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is 0.1937, which occurs at IR = 0.55, around the upper bound. Beyond these boundary
IR values, no dominant peak can be observed in the amplitude spectrum, reflecting the
fact that there is no sustained oscillation. Within the oscillatory region, we observe a
monotonical decrease of the frequency when IR level increases. This is consistent with
the observation in the time domain simulation which shows that the period increases
when IR value increases. To confirm this, the DDE-BIFTOOL [29] is used to obtain a
plot of period of oscillation against IR values as shown in Figure 2.11, whose result is
consistent with our frequency analysis. In [33], the authors stated that the period of
oscillations did not appear to significantly depend on irradiation level. As investigated
here, the period correlates to the IR dose. Therefore, more explorations need to be
carried out.













Figure 2.11: Period of oscillation against different IR values analyzed by DDE-
BIFTOOL [29]
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2.5.2 Experimental Design
Based on the above analysis, a frequency shifting phenomenon is predicted by the math-
ematical model. As stated earlier, one purpose of performing frequency analysis is that it
will help to determine the number of samples (N) and sampling frequency (Fs) necessary
in the practical experiment such that the original signal is not distorted. N determines
the total number of data points needed to sample the concentration of p53 while Fs
determines how frequent the measurements need to be made. By optimally selecting N
and Fs, much cost and time can be saved for carrying out the verifying experimental
design. Here, we do not intend to adopt the optimization formulation, such as linear or
nonlinear programming, as introduced in [4].
For DFT operation, perfect reconstruction of the original time domain signal from
the discrete time samples requires k = N F0Fs to be an integer where F0 denotes the
dominant frequency in the input signal. This is to guarantee that the DFT result can
represent the original signal perfectly in the frequency domain. Else, the frequency
domain representation is only an approximation of the original signal. Bearing this in
mind, the method proposed here is to fix Fs as an integer multiple of F0, e.g. Fs = 3F0.
N can then be chosen as any multiple of 3 and k will always be an integer. In other words,
as few as 3 samples are required to obtain the frequency domain representation of the p53
concentration theoretically. In fact, this is an ideal case because the Nyquist frequency
merely gives the lower bound of the sampling frequency. In practice, we usually need
higher frequency than that to prevent aliasing problem due to the existence of noise.
However, the balance between the accuracy and the cost must be taken into account.
Therefore, following the aforementioned design, the DFT condition can be satisfied while
the time and cost of conducting the verifying experiment can be minimized.
With the previous simulation result, the predicted frequency F0 with respect to
different IR values can be obtained. Hence corresponding Fs can be calculated. Herein
one thing to note is that F0 obtained in the simulation may not be the same as the actual
frequency of oscillation obtained in experiment. Therefore, further adjustments of Fs
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and N might be needed in practice since the model presented here is more of qualitative
nature. However, the method presented here can be employed directly as guidelines of
designing experiments provided that a reasonably reliable mathematical model is built.
Therefore, a suggested experiment procedure could be designed as follows.
1. Build a quantitative-reliably enough mathematical model from more available
datasets
2. Select the stable oscillatory simulated data to be dealt with by Matlab routine
FFT, and identify the dominant predicted frequency F0
3. When performing the experiment, measure the concentrations of p53 and Mdm2
every T (= 1n×F0 ,where n = 4, 5 . . .) time after entering the steady oscillation
stage
4. Collect N (= k × n,where k = 2, 3, . . .) numbers of data points in total
5. Reconstruct the actual oscillation including amplitude and frequency information
from the collected data points after filtering the noise signal
2.6 Discussion
The threshold mechanism discovered by the bifurcation analysis has not been verified
by the current experimental data so far. Hence, a verifying experiment is suggested to
be conducted. Once the experiment is done, two scenarios may occur. On one hand, if
a higher steady state of p53 is observed, which coincides with the prediction from the
model, the model is validated, revealing true mechanisms in the core regulation to some
extent. On the other hand, if the observation shows that there are still sustained p53
oscillations or low level of stable steady state, then we have to refine or revise our current
model. More aspects, such as the downstream activities of p53, which are involved in
cell cycle, apoptosis and detailed DNA repair process [35], may have to be considered
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to improve the model’s reliability, or, the role of ATM should be re-evaluated to modify
the interactions with the core regulation.
Regarding the frequency analysis, the predicted frequencies are normalized by the
sampling frequency and converted from dimensionless time factor. According to Ta-
ble 2.2, we can easily discriminate the differences in the frequency domain, and the
practical measurement period usually takes several hours to days. Therefore, it is be-
lieved that the differences in the time domain are considerable in reality.
Furthermore, the real dominant frequency of p53 oscillations awaits more experi-
mental data to be determined precisely. This real frequency will help to improve the
model and design the experimental procedure. First, it can be utilized to refine parts
of time-related parameters, such as degradation rate, repairing rate, etc. Secondly, with
the knowledge of real frequency, it can replace the step 1 and 2 of the experimental pro-
cedure mentioned in Section 2.5.2. The following steps could get along directly without
the help of mathematical model. Moreover, the concentration information is necessary
for accurate reconstruction in practice. At this point, measurement techniques need to
be improved to accomplish this.
Admittedly, with the existence of the inevitable noises and fluctuations under current
technical status, the guideline provided is somewhat conceptual, still requiring further
fine tuning and modifications with respect to practical considerations, such as noise
filtering, statistical data processing, etc. Handling the noise is an open question in
quantitative systems modelling. There are several ways for noise reduction besides
the statistical inference of data. First of all, technical improvements help to make
high-precision measurements [71]. Secondly, considering the variability between cells,
stochastic modelling methods will comply with the natural essence more compared to
deterministic modelling [59]. Thirdly, it is required to develop method to position the
noise origin [6] and use specific mechanisms to lower the noise impact [75]. Therefore,
it is a long way to fully develop quantitative computational biology.
In the current model, the variable dam, representing DNA damage, helps to resemble
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the damped oscillation after irradiation. The simulation results show that the magnitude
of oscillations will monotonically decrease after the impulsive stimulus of irradiation,
which depends on the degradation time constant T2 in Eq.(2.11). Without the variable
dam, the ATM’s influence will fast disappear through a decaying dynamics, i.e. the
oscillation will not persist for a long duration, which violates the common observations.
Besides, ATM is expressed as the independent variable of Hill function in Eq.(2.6) and
Eq.(2.8). The selection of K1 and K2 plays an important role for the tuning effects of
ATM, which need to give enough tuning range for ATM. Otherwise, ATM will become
dispensable.
To emphasize again, our main focus here is to develop a predictive mathematical
model such that it recaptures the observations and provides new insights. So far, the
model is a scaled version and semi-quantitative, and the parameters are mostly esti-
mated by approximations or trial-and-error. This is due to the lack of quantitative
reliable experimental data, such as the real-time concentrations. Our emphasis is to de-
termine which variables to be included and identify their relationships than the precise
values [108]. Once new data become available, the model can be refined and make more
accurate predictions.
2.7 Conclusion
In this chapter, a new mathematical model was proposed to explain the inherent mech-
anisms in p53-Mdm2 core regulation in response to DNA damage. The selections of the
components and the dynamical relations among them were based on biological facts and
reasonable approximations. Nevertheless, many factors or details were not included,
such as DNA repair mechanisms, the volume ratio of cytoplasm and nucleus where
proteins and messenger RNAs are exported in and out, etc.
The main structure was built in delayed differential equations. The simulation en-
vironment was in Matlab mainly using dde23 [88]. Selections of parameters and sim-
plification assumptions were proven qualitatively appropriate by the good agreement
32
2.7 Conclusion
of simulation results with the experimental phenomena. Admittedly, parameters are
scaled version and most of them were obtained from trial-and-error. They are far from
the real values, which require to be refurnished in an iterative way. With the new-coming
evidence, we are confident the model will become more capable.
In addition, a more detailed investigation was performed to analyse the bifurcation
of p53’s concentration with respect to the dose of ionizing radiation to predict a new
threshold mechanism used to explore this core regulation. Meanwhile, the phenomenon
of frequency shifting was observed from the simulation results. To help discriminating
different frequencies, Fourier frequency analysis was applied to transform the oscillations
in the time domain to distinct pulses in the frequency domain. Furthermore, based on the
dominant frequency identified, an experiment procedure was provided to give suggestion
on sampling frequency and data point number for the wet lab.
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Chapter 3
Model Validation of Petri Net for
Apoptosis Pathways
In this chapter, we enlarge our picture to build a model of p53-dependent apoptosis
pathways, which establish the environment for the investigation of microRNA. To avoid
the burdens to identify the numerous parameters in ordinary differential equations, we
resort to discrete formalism—Petri net—to describe the inter-connections among the
components. Furthermore, we propose two approaches to verify the discrete model’s
reliability. The work in this chapter paves the way for the next-step exploration.
3.1 Introduction
3.1.1 Classical Apoptosis Pathways
Apoptosis is a well-regulated cell death process which is required for development of
normal tissues and suicide of threatening cells. A mostly used example is the resorp-
tion of the tadpole tail at the time of its metamorphosis into a frog. Malfunction of
this process will result in severe diseases, such as cancer. There is another form of cell
death called cell necrosis. Cells that die induced by acute injury will swell and burst,
spilling their contents to the environment. This eruption triggers a potentially damag-
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ing inflammatory response. Different with necrosis, apoptosis happens gently without
damaging neighbours, expressing in the shrink and condense of cell content, collapse of
cytoskeleton, engulfment by phagocytic cells [2].
This phenomenon was first studied in Caenorhabditis elegans. In this organism, 1090
somatic cells are generated in the formation of adult worms, of which 131 of these cells
die at particular points, which is invariant between worms, showing that there must be
an accurate and programmed control mechanism in nematode. So apoptosis is also called
cell programmed death [40]. Apoptosis is conserved in higher organisms. Although it
is studied for almost 30 years, the whole process remains to be elucidated. The huge
number of molecules and interactions put difficulties in the way of understanding on
this process.
As is known, the classical apoptosis pathways can be mainly divided into two types—
extrinsic pathways and intrinsic pathways [28]. No matter which type is applied, the
whole process will be mediated by the caspases, a family of proteases. Caspase will
catalyse the hydrolytic breakdown of proteins, such as the lamin proteins, which form
the nuclear lamina underlying the unclear envelope. The functions are performed in
a cascaded style, i.e. the activated caspases will active other members of the family,
resulting an amplifying cascade process. The initial procaspase, inactive precursors of
caspase, is triggered by the apoptosis signal, e.g. DNA damage, γ radiation, UV light,
survival signal withdrawal and signalling from the death receptors.
Extrinsic pathways involve transmembrane receptor mediated interactions. The
death receptors, most of which are members of tumour necrosis factor (TNF) receptors,
are bound by respective natural ligands, leading the death domain (DD) of the receptor
transmitting the signal from the cell surface to the intracellular signalling pathway. Re-
sorting to the adaptor protein, the death-inducing signalling complex (DISC) is formed.
This complex consists of procaspase-8, procaspase-10, adaptor protein, e.g. FADD,
and c-FLIP, which will inhibit the activities of caspase-8 and FADD. The formation of
DISC will result in the autocatalytic activation of procaspase-8, which is followed by the
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activation of caspase-3—the main executioner caspase, and the consequent proteolytic
cascade.
Intrinsic pathways include a different way to trigger the caspase cascade[2][54].
Non-receptor stimuli, such as oncogene stress, DNA damage, hypoxia, will deliver the
proapoptotic and antiapoptotic protein, all of which are members of BCL-2 family,
to the mitochondria surface, positively or negatively resulting in an opening of the
mitochondrial permeability transition (MPT) pore, allowing the release mitochondria
protein into the cytosol. The group of mitochondria proteins consists of cytochrome
c, Smac/DIABLO. Cytochrome c binds and activates Apaf-1 and procaspase-9 as well,
forming an “apoptosome”. Apoptsome will trigger a caspase cascade, initiating caspase-
3, finally leading to apoptosis. Smac/DIABLO will promote apoptosis by reducing in-
hibitors of apoptosis protein (IAP) activity.
All the above introduction could refer to Figure 3.1.
Figure 3.1: extrinsic and intrinsic apoptosis pathway
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In the intrinsic pathways, p53 is the transcription factors of Bcl-2 family members,
pro-apoptosis protein BAX, Puma, Noxa. As for the extrinsic pathway, Fas(CD95/Apo-
1) is also the target. All these targets are crucial elements in this whole process. So
the importance of p53 is obvious and p53’s importance in apoptosis has been widely
accepted. The pictorial description is shown in Figure 3.2.
Figure 3.2: Block Diagram of p53-apoptosis pathway. Arrow represents activation; bar-
headed line represents inhibition; circle-headed line represents catalysis.
There are also several survival pathways which influence the cell death activities,
such as growth factor related pathways, NFκB related pathways, etc. More details
about survival pathways could be found in Chapter 4.
3.1.2 Objective
Systems biology is a field of growing importance in biology research. It is concerned
with the modelling, simulation and analysis of biological processes within a modelled
biological system. By harnessing the vast calculative power of computer systems, a
systems biological approach with a model at its centre can break the bottleneck of wet
lab research to make new discoveries [48].
Naturally, a strong and accurate model is required before we can start to tap the
calculative power of computers. There is thus a cyclic process in model development
that requires the validation of the model, ensuring that the intended biological processes
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that have been modelled have some forms of mathematical representations [107]. Due to
limited experimental data, it is unavoidable to have incomplete or even wrong models.
Therefore, it is a critical task in systems biology to check the model’s correctness, which
is called model validation problem. For example, in the genetic regulatory network, in-
complete information of relations will lead to uncertainties of connections among genes
and regulatory proteins. Sometimes, the model needs to tolerate the inconsistent infor-
mation from different sets of experimental data. Under such circumstances, the models
are required to be step-wisely developed and validated to increase the confidence to
reflect the reality.
Model validation is commonly addressed by simulation and test method, which veri-
fies the model performance by the agreement with the data points. For example, in [41],
the models describing different binding conditions of Bcl-2 to pro-apototic proteins were
tested by comparing the simulation results with the observed experiment data. In dis-
crete domain, one sophisticated approach is model checking. The system is modelled
by certain form of transition system. The algorithm will exhaustively search all the
reachable states avoiding the miss of any single state. Due to the efficiency, it could
be introduced to large-scale networks. Therefore, most discrete formalisms are applying
model checking to do the validation tasks, such as the work done in [10, 16]. In our
work done in Chapter 4, we also adopt the underlying idea to solve the problem of
target validation of microRNAs. However, in this chapter, two solutions are provided to
address model validation issue. Both are based on the analysis of basic state equations
under Petri net framework, which are considered as most straightforward way to solve
model validation problem. One is based on the invariant analysis; the other one is based
on the reachability analysis.
In the sequel, the background of Petri net formalism is introduced in Section 3.2, and
the necessary theoretical bases are followed immediately. In Section 3.3, the modelling
of apoptosis pathways is presented followed by the invariant analysis result on it in
Section 3.4. The reachability analysis in Section 3.5 includes two approaches to do the
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validation and one artificial example and case study are used to illustrate the procedures
accordingly. Finally, this chapter ends with the concluding words.
3.2 Petri Net
3.2.1 Petri Net Introduction
Petri nets have a graphical representation of discrete event system. Simple but pragmatic
interface makes Petri nets user-friendly and popular. Since 1960s, Petri nets have been
widely employed to model the systems of computer science, communication protocol
and industrial management, etc [68].
Petri net is chosen as a modelling approach for biological system because of the
natural affinity in three folds. 1) Biological systems are bipartite, consisting of the
species/substrates and their interactions. 2) They are concurrent, allowing several in-
teractions to take place simultaneously and independently of each other. 3) Finally, the
interactions are stochastic and non-deterministic. Bearing these features, Petri net was
firstly employed to model biochemical systems in [79]. From then on, Petri net and its
extended variants are popular modelling frameworks for biological networks [22, 57].
A Petri net is a directed, bipartite multi-graph. Bipartite nodes consist of places and
transitions. Graphically, places are denoted as circles, and transitions are rectangles or
bars. Arcs are used to connect places with transitions. Same types of nodes have no
arcs linking in between.
The meanings of the transitions and places depend on the modelling context. For
example, in event/condition systems, a transition stands for the occurrence of an event,
while the input places of the transition are the pre-conditions, all the necessary con-
ditions needed to trigger the event; and the output places are post-conditions, all the
conditions satisfied after the occurrence of the event. In biochemical reactions, transi-
tions represent chemical reactions. The input places and output places are respectively
the reactant compound and product compound in these reactions. Sometimes, one net
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can have mixed types of places and transitions for different interpretations.
Petri nets are executable. The execution is based on the idea of tokens, which are
graphically depicted by dots and reside in places. The distribution of tokens in places
is called marking. Firing of transitions will change the distribution of tokens. Hence,
Petri net is also dubbed “token game”. The marking of all places comprises the state
space of Petri net. One example is given in Figure 3.3.
Figure 3.3: Petri net example showing the synthesis of water molecule. There are 3
places, H2, O2 and H2O, 1 transition T0. The weights of arc connecting from place H2
to transition T0 and T0 to place H2O are 2. The weight of arc connecting from O2 to
T0 is one, usually omitted by default.
The definitions of Petri nets are mathematically expressed in the following forms,
which are adapted from [68].
Definition A Petri net is a 5-tuple, PN = (P, T, F,W,M0) where,
P = {p1, p2, · · · , pm} is a finite set of m places,
T = {t1, t2, · · · , tn} is a finite set of n transitions,
F ⊆ (P × T ) ∪ (T × P ) is a set of arcs,
W : F → {1, 2, 3, · · · } is a weight function,
M0 : P → {0, 1, 2, 3, · · · } is the initial marking,
P ∩ T = ∅ and P ∪ T 6= ∅.
The weight of an arc from place pi to transition tj , and from transition tj to place pi is
represented as w(pi, tj) and w(tj , pi), respectively. The pre- and post-set of transitions
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t ∈ T are •t = {p | w(p, t) > 0} and t• = {p | w(t, p) > 0}, respectively. Similarly, the
pre- and post-set of places p ∈ P are •p = {t | w(t, p) > 0} and p• = {t | w(p, t) > 0},
respectively. The state of a Petri net is the marking M : P → {0, 1, 2, · · · }, a non-
negative integer-valued vector. The i-th component of the marking vector, denoted by
M(pi), represents the number of tokens at place pi.
Definition A transition is said to be enabled in marking M , if all places in its pre-set
have at least as many tokens as the weights of the arcs connecting those places to the
transition, that is, if ∀p ∈ •t,M(p) ≥ w(p, t), transition t is said to be enabled in the
marking M .
Definition Firing an enabled transition changes the token distribution by removing as
many tokens as the weights on the arcs leading in from all its pre-set places and adding
as many tokens as the weights on the arcs leading out to all its post-set places, that




M(p)− w(p, t) ∀p ∈ •t
M(p) + w(t, p) ∀p ∈ t•
M(p) ∀p /∈ {•t ∪ t•}
In the example shown in Figure 3.3, the transition T0 is enabled, and firing the transi-
tion makes the marking change from M0(H2,O2,H2O) = [3 1 1]
T to M1(H2,O2,H2O) =
[1 0 3]T .
These changes in the state of the system can be represented in an algebraic form
using the state equations given by
Mk = Mk−1 + CTuk,
where C = [cij ] is an n ×m incidence matrix of integers; the superscript T stands for
transpose; uk is called firing or control vector, which is an n× 1 column vector of n− 1
0’s and one nonzero entry, a 1 in the i-th position indicating that transition i fires at
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the k-th firing. The typical entry of incidence matrix C is given by
cij = c
+
ij − c−ij ,
where c+ij = w(i, j) is the weight of the arc from transition i to its output place j and
c−ij = w(j, i) is the weight of the arc to transition i from its input place j.
Theorem 3.2.1 (Necessary Reachability Condition)[68] Suppose that a destination mark-
ing Md is reachable from initial marking M0 through a firing sequence
{u1,u2, · · · ,ud}.
The state equations can be derived as follows.





which can be rewritten as
CTx = 4M, (3.2)
where 4M = Md −M0 and x =
∑d
k=1 uk.
Here x is an n × 1 column vector of non-negative integers and is called the firing
count vector. The i-th entry of x denotes the number of times that transition i must
fire to transform M0 to Md.
3.2.2 Invariant Analysis
• Transition invariant: Suppose X has non-negative integers as entries and CTX =
0. Then X is called transition invariant, also called T-invariant. Stated differ-
ently, in any execution which corresponds to X, the resulting marking is the same
the initial marking. The physical meaning is that there is no net change in the
concentration levels and the system enters steady state.
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• Place Invariant: Suppose Y has non-negative integers as entries and CY = 0.
Then Y is called a place invariant, also called P-invariant. That’s to say, the sum
of all tokens multiplied by the weigh of the corresponding place is invariant. The
Y-weighted count of any reachable marking M is equal to the Y-weighted count
of M0.
3.2.3 Reachability Analysis
By Theorem 3.2.1, the existence of a non-negative integer-valued solution of state equa-
tions (3.2) is a necessary condition for the reachability of Petri net, i.e. if the destination
marking Md is reachable from the initial marking M0, there exists non-negative integer
solution for state equations (3.2). The sufficiency of this condition is only restricted to
acyclic Petri nets, a subclass of Petri nets. Acyclic Petri net, having no directed circuit,
belongs to such class of Petri nets [43].
3.3 Modelling of Apoptosis Pathways
3.3.1 Model Structure
The apoptosis modelling by Petri net was discussed in the paper by Heiner et al [38].
T-invariant analysis was performed on their model as a means of analysis and model
validation. It is of interest to see what a related analytical calculation, the P-invariant
analysis, will reveal if it is performed on the model.
While the model developed by Heiner et al [38] is used as a starting point to build the
model, for P-invariant analysis to be possible, it is necessary for a couple of structural
differences to be put in place.
Firstly, input and output transitions must be excluded. Input transitions are tran-
sitions providing tokens to a place but do not consume tokens from other places. Con-
versely, output transitions remove tokens but do not provide tokens to any place. These
“boundary” transitions are found in Heiner’s model together with substrates that oth-
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erwise did not have any means to gain or lose tokens.
Secondly, inhibitory interactions must be modelled because many such interactions
take place within the apoptotic pathways, such as between Bcl-2 and Bax [90]. Such
interactions usually involve the consumption of both the inhibiting substrate and the






Figure 3.4: Inhibiting transition D between place A and B.
Figure 3.4 shows the representation of such an inhibiting interaction D between sub-
strates A and B forming the inactive substrate complex A∧B. This consumes tokens
from B and down-regulates the occurrence of the “forward” reaction C. Although con-
ceptually substrate A is the inhibiting species and B the inhibited species, A and B are
considered mutually inhibiting since both are consumed in the inhibitory process.
These two structural features of the model are necessary for P-invariant analysis to
be carried out, which will be explained later.
3.3.2 Petri Net Model
The basic mechanisms and processes could refer to the background introduction in
Section 3.1.1. The modelling is also borrowing the evidence from the following additional
sources [96, 28, 92, 46, 90, 42, 61, 30, 76, 89, 86, 11].
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Extrinsic Pathway
Figure 3.5 shows the partial Petri net model of the extrinsic pathway as described by
the above sources. The formation of the DISC (Death Inducing Signaling Complex)
can be seen as a stepwise incorporation of such substrates as the Fas ligand (FasL),
Fas receptor (Fas, activated by p53), Fas-associated protein with death domain (Fadd)
and procaspase-8. DISC then releases the active caspase-8, which triggers the caspase
cascade involving caspase-3. Caspase-8 itself is deregulated by cFLIP. All place names
with a ∧ symbol represent inactivated species.
Intrinsic Pathway
Figure 3.6 shows the model of the intrinsic pathway as described by the sources. Up-
regulation of NOXA and PUMA by p53 and their deactivation of Bcl-2 is modelled.
Bax, which is up-regulated by p53 and down-regulated by Bcl-2, releases cytochrome c
from the mitochondria. This stimulates the formation of the apoptosome, which cleaves
and activates caspase-9 from its pro-form, initiating the caspase cascade just like in the
extrinsic pathway.
Various inhibitory interactions are modelled, such as between SMAC/DIABLO and
IAP, between IAP and executioner caspase-3 and procaspase-9, as well as between pro-
and anti-apoptotic substrates Bax and Bcl-2.
It should be noted that for model simplicity and readability, several places in the
model represent more than one substrate indicated by its place name. These substrates
share similar functions and a fair extent of redundancy. Substrates that represent mul-
tiple similar substrates are shown in Table 3.1.
Roles of Bid
Finally, Figure 3.7 shows the partial model of the functions of Bid (tBid) as it is up-
regulated by caspase-8. This provides a link from the extrinsic pathway to the intrinsic
pathway. By releasing SMAC/DIABLO and cytochrome c, as well as inhibiting Bcl-2,
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Figure 3.5: Modelling the extrinsic pathway
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Figure 3.6: Modelling the intrinsic pathway
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Table 3.1: Multiple substrates represented by single substrate
Name Substrates Represented
Fas Death receptors including Fas and TNFR1
FasL Ligands of death receptors including FasL
and TNF-α
Fas trimer Complex of 3 death receptors with ligands
FADD Fas Protein with death domain related to death receptor
procaspase 3 Procaspase-3, -6, -7
caspase 3 Active executioner caspases(-3, -6, -7)
Bax Proapoptotic Bcl-2 family proteins
(Bax, Bak, etc.)
Bcl-2 Antiapoptotic Bcl-2 family proteins
(Bcl-2, Bcl-XL, etc.)
the role of tBid in the intrinsic pathway is similar to Bax. An intermediate caspase 8 i
is introduced along with a transition t x to characterize the enzymatic interaction which
caspase-8 has on Bid. In this way, this “crossing-over” phenomenon will not cause a
breakdown in the extrinsic pathway in which Bid is always competing for caspase 8
tokens, preventing the extrinsic caspase cascade.
These three net components are intentionally displayed in this work separately to
promote readability and at the same time distinguish them as major pathways. The
full net model can be obtained by joining together the three partial models at the place
nodes indicated in grey.
3.4 P-invariant Analysis Result
Heiner et al. have established this ability with T-invariant analysis [38]. It would be of
interest to see if P-invariant analysis could be used to the same purpose. In this section,
P-invariant analysis will be performed on the above Petri net model, and ultimately
established as a means of validating the model.
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Figure 3.7: Modelling the roles of Bid
3.4.1 P-invariant of Model
P-invariant analysis allows the identification of conservatory networks that always main-
tain a certain conservation of tokens. Applied to the model, it is hoped that networks
containing substrates (places) that are related by a certain signal transduction pathway
would emerge as the invariants. The conservation of tokens can be interpreted as a
conservation of the same biological signal within the network. Hence, places that are
linked in a P-invariant are possibly linked by the same biological signal.
The structural changes as mentioned in Section 3.3.1 are necessary so that there
will not be any unregulated flow of tokens into/out of the net via input and output
transitions. Otherwise, this would make P-invariants impossible since weighted sum of
tokens would then be uncontrolled. Inactive species are also included as a way to provide
conservation of tokens for every transition, in order for their firings to be tracked by
P-invariant analysis.
Using the Snoopy software [80] to construct the Petri net and its companion software
Charlie [26] to perform P-invariant analysis, 13 P-invariants are found. These invari-
ants, and their constituent places including deactivated/inactive substrates are listed in
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Table 3.2 below.
3.4.2 Interpretation of P-invariant
To make sense of the invariants, critical places in the invariants need to be identified
first. Two such critical places are places that do not have any incoming edges, and those
that do not have any outgoing edges, which can be aptly termed start and stop places,
respectively. For example, in the first invariant, cFLIP is a start place and caspase 8∧
is a stop place (refer to Figure 3.5). While there may be multiple stop places or start
places per invariant, there must be at least one of each per invariant.
After these critical points have been identified, the rest of the places can be used to
link the start place to the stop place using any combination of transitions and edges in
between. In doing so, conservatory signalling pathways originating from the start place
can be traced out to their final destination.
Identified P-invariants can thus be interpreted by considering them with respect to
the start and stop places. Table 3.3 shows the list of P-invariants and their interpreted
biological significance.
Invariants 6, 7, 8 and 9 are connected to each other because they all identify the same
interactive pathway. The only difference lies in the starting places (procaspase 8, Fadd,
Fas, and p53, respectively) that finally lead to the caspase cascade via the extrinsic
pathway. In invariant 9, p53 is the starting place and its pro-apoptotic killing activity
of anti-apoptotic signals originating from Bcl-2 and IAPs can be easily identified.
Invariants 10, 11, 12 and 13 are also connected because of the same four different
starting points (as in invariants 6 to 9) mentioned above.
In fact, invariants 5, 9 and 13 are also connected and do not identify any unique
interactive pathway. The only difference is the choice of the starting point for the
“lower” segment of the intrinsic pathway. In invariant 5, it is Bax that starts the
propagation of signal via cytochrome c, leading to the caspase cascade; in invariant 9,
APAF-1 is implicated for the same reaction, and in invariant 13, it is procaspase 9.
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Table 3.2: P-invariants and places involved
No. Places in P-Invariant
1 cFLIP, caspase 8∧
2 Bcl-2, Bcl-2∧, Bax∧/Bcl-2∧
3 procaspase 3, caspase 3, caspase 3∧
4 IAP, IAP∧, procaspase 9∧, caspase 3∧
5 p53, NOXA PUMA, Bax, Bcl-2∧, Bax∧/Bcl-2∧,
cytochrome c,Apoptosome, caspase 9, caspase 3,
caspase 3∧, Fas, Fas trimer, FADD Fas, DISC,
caspase 8, caspase 8∧, caspase 8 i, Bid, tBid
6 APAF-1, Apoptosome, caspase 9, caspase 3, caspase 3∧,
procaspase 8, DISC, caspase 8, caspase 8∧, caspase 8 i
7 APAF-1, Apoptosome, caspase 9, caspase 3, caspase 3∧,
Fadd, FADD Fas, DISC, caspase 8, caspase 8∧, caspase 8 i
8 APAF-1, Apoptosome, caspase 9, caspase 3, caspase 3∧,
FasL, Fas trimer, FADD Fas, DISC, caspase 8, caspase 8∧,
caspase 8 i
9 p53, NOXA PUMA, Bax, Bcl-2∧, Bax∧/Bcl-2∧, SMAC,
IAP∧,APAF-1, Apoptosome, caspase 9, caspase 3,
caspase 3∧, Fas, Fas trimer, FADD Fas, DISC, caspase 8,
caspase 8∧,caspase 8 i, Bid, tBid
10 procaspase 8, DISC, caspase 8, caspase 8∧, caspase 3,
caspase 3∧, procaspase 9, procaspase 9∧, caspase 9
11 Fadd, FADD Fas, DISC, caspase 8, caspase 8∧,
caspase 3, caspase 3∧, procaspase 9, procaspase 9∧, caspase 9
12 FasL, Fas trimer, FADD Fas, DISC, caspase 8, caspase 8∧,
caspase 3, caspase 3∧, procaspase 9, procaspase 9∧, caspase 9
13 p53, NOXA PUMA, Bax, Bcl-2∧, Bax∧/Bcl-2∧, SMAC, IAP∧,
procaspase 9, procaspase 9∧, caspase 9, caspase 3, caspase 3∧,
Fas, Fas trimer, FADD Fas, DISC, caspase 8, caspase 8∧,
caspase 8 i, Bid, tBid
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Table 3.3: P-invariants interpretation
No. P-Invariant Interpretation
1 cFLIP resulting in deactivation of caspase-8
2 Antiapoptotic Bcl-2 family used in inhibiting proapoptotic
signals, or deactivated by NOXA and PUMA
3 procaspases being activated into caspase-3, -6, -7, and
deactivated by IAP
4 IAPs deactivating procaspase-9 and caspase-3, -6, -7, or being
deactivated by SMAC
5 p53 resulting in deactivation of Bcl-2, and activation of caspase
-3, -6 and -7 via extrinsic and intrinsic pathways. Caspase-8
and tBid involvement into the intrinsic pathway is also shown.
6 same as 9
7 same as 9
8 same as 9
9 p53 resulting in deactivation of Bcl-2, deactivation of IAP, and
activation of caspase-3, -6 and -7 via extrinsic pathway only.
Caspase-8 and tBid activity into the intrinsic pathway is also
shown. APAF-1 is shown as the stimulus for the intrinsic
pathway.
10 same as 13
11 same as 13
12 same as 13
13 p53 resulting in deactivation of Bcl-2, deactivation of IAP, and
activation of caspase-3, -6 and -7 via extrinsic pathway only.
Caspase-8 and tBid activity into the intrinsic pathway is also
shown. Procaspase-9 is shown as the stimulus for the intrinsic
pathway.
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Hence, invariants 5 to 13 collectively represent the workings of both the extrinsic and
intrinsic pathway, each identifying a different substrate that is important as a starting
requirement for the pathways. Such substrates include (as represented by their places)
p53, death receptor and ligand, proteins with death domains, procaspase-8, APAF-1
and procaspase-9.
The presence of multiple invariants that have the same biological significance is
primarily due to places that only serve a single function of being a substrate for the next
reaction. Such places, like APAF-1, and Fadd, do not affect the signalling pathways in
more meaningful “secondary” ways other than simply being present for the next step
to occur. An extended Petri net that involves these places in other dynamic ways will
eliminate this problem of “repeated invariants”.
It is noted that caspase 3∧ is the stop point in invariants 5 to 13. This, however, does
not mean that both the intrinsic and extrinsic pathways always end up in deactivated
caspases-3, -6 and -7 (and hence termination of apoptosis). Caspase 3∧ is the stop
point in this case because further pathways downstream of caspase 3, i.e. the execution
pathway [90], are not included in the model.
In the model, caspase 3 is taken to be equivalent to the trigger of apoptosis itself,
since it is assumed that high levels of caspases-3, -6 and -7 would always lead to the
execution pathway. In this right, caspase 3∧ should be viewed as a stop place while
interpreting the P-invariants.
3.4.3 Model Validation using P-invariant
The full list of biological activities involved in the Petri net model, as identified through
P-invariant analysis is thus given as follows:
• Main Extrinsic Pathway leading to apoptosis
• Main Intrinsic Pathway leading to apoptosis
• Deactivation of caspase-8 by cFLIP
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• NOXA and PUMA’s upregulation by p53, deactivating anti-apoptotic Bcl-2 family
members
• Mutual inhibition between pro- and anti-apoptotic Bcl-2 family members
• IAPs deactivating procaspase-9 and caspases-3 and -7
• SMAC/DIABLO deactivating IAPs
• Upregulation of tBid by caspase-8 to facilitate intrinsic pathway
This list fully includes all biological processes that have described in the sources [96,
28, 92, 46, 90, 42, 61, 30, 76, 89, 86, 11]. It is thus evident that P-invariants can be
employed to analyse and validate extended versions of this Petri net model and similar
signalling transduction networks.
3.4.4 Discussion
P-invariant analysis has thus been established as an additional method of validating
Petri net models of signalling transduction networks. It is recommended that addi-
tional validation techniques, such as T-invariant analysis, be used in conjunction with
P-invariant analysis, described in this section, when validating models, so as to further
increase model confidence and prevent over-reliance on a single technique.
Besides validation via P-invariant analysis, the model used in this section has also
been validated using T-invariant analysis. The results of the T-invariant analysis are
the same as those compiled in Section 3.4.3. Common mechanisms can also be found in
Heiner’s work.
Compared to P-invariant analysis, T-invariant analysis also requires a set of struc-
tural requirements. P-invariant analysis will provide some overlapping pathways as
shown in the last section. In this aspect, the results by P-invariant is not so intuitive
as the ones by T-invariant. However, the P-invariant results reveal the complementary
evidence to T-invariant.
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The confidence of protein-protein interactions indicated in this work is thus strong
enough for it to be the subject for future developments and model extensions, so as
to better study the intrinsic and extrinsic apoptotic pathways. Besides including more
substrates as more discoveries are made by the scientific community, improvements such
as a quantitative model can be considered.
3.5 Reachability Analysis Result
3.5.1 Problem Formulation
In this section, we will validate the Petri net model based on the reachability analysis.
The necessary condition mentioned in Theorem 3.2.1 could be treated into the following
two scenarios, which will give hints to do the model validation in systems biology.
First of all, the contrapositive of the necessary condition provides a sufficient con-
dition for unreachability, i.e. if the state equations do not have non-negative integer
solutions, Md is not reachable from M0. This condition can be used to test the unreach-
ability of certain states. Furthermore, in the acyclic case, this condition is used to test
both the reachability and unreachability of concerned states at the same time.
In the biological context, taking the genetic regulatory pathways for example, this
condition could be utilized to test the expressions of certain genes. Initial marking could
be generated according to the initial expression information. The incidence matrix could
also be constructed when the relations among the genes are identified. Then, this con-
dition may help to verify the biologists’ hypotheses on the interested gene’s expression.
It can be imagined that we may often eliminate some impossible guesses through the
state equations, which will save remarkable cost and energy for the experimenters.
Secondly, if the expression data are observed, which means, in Petri net formalism,
the state equations should be definitely solvable. If it has non-negative integer solutions
accordingly, the model of current Petri net is validated. It can be further analysed to
get more insights and generate further hypotheses based on the current model. If there
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does not exist a non-negative integer solution, the incidence matrix C is somehow wrong.
We have to modify the structure of the Petri net, such as the connections and weights,
reflecting the reactions and stoichiometric parameters.
To address this problem, we introduce the following two approaches. One is the
Smith normal form based criterion, which is established to check the reachability of
desired states. It is shown that if the condition violates the criterion, the state equations
are unsolvable. Accordingly, the desired state cannot be reached. The other approach
is to test the model structure by the solvability of state equations under different initial
conditions. The model which agrees with known evidence will be retained. Integer
programming is introduced to facilitate this problem.
3.5.2 Diophantine Equations
The discussion in the last section transforms the reachability problem to the existence
of non-negative integer solutions of state equations (3.2). By inspection of the state
equations, the entries of the incidence matrix are all integers. Additionally, the solutions
are also required to be integers, which is correlated to the Diophantine Analysis.
In mathematics, a Diophantine equation is an indeterminate polynomial equation
that allows the variables to be integers only. The solvability of Diophantine equations
is proposed as the tenth of Hilbert problem. In general, Diophantine problems are un-
solvable. But in the case of linear Diophantine equation, Be´zout’s identity is a perfect
solution [44]. Be´zout’s identity is specific to one linear Diophantine equation with multi-
ple unknowns. In the sequel, we will analyse a set of Diophantine equations using linear
algebraic method first. Then, this problem will be reformulated as integer programming
(IP), and the state equations are solved numerically.
3.5.3 Approach by Smith Normal Form Test
The Smith normal form applies for any matrix with entries in a principal ideal domain
(PID). In particular, the integers are PID, so one can always calculate the Smith normal
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form for an integer matrix [106].
Theorem 3.5.1 [72] If A = (aij) is any integer matrix of order m × n with rank r,
then there exists a unique integer matrix
Dm×n =

d1 0 0 · · · 0 · · · 0






... dr 0 · · · 0






0 0 · · · · · · · · · 0

,
where dk > 0, k = 1, · · · , r, and dk divides dk+1. D is the Smith normal form of A, and
{d1, d2, · · · , dr} are called invariant factors. Furthermore, the matrices A and D are
equivalent (A ∼= D), i.e. A = PDQ for some unimodular square matrices P of order m
and Q of order n.
The Smith normal form D can always be obtained through a series of elementary
row and column operations on the original matrix A by left-multiplying matrix P and
right-multiplying matrix Q correspondingly. Several software packages are also available
for this computation, such as Fermat, GAP, MAGMA and so on.
The classical method using the Smith normal form to solve the linear Diophantine
equations is described in [72]. In the following, one simple criterion to test the the
existence of integer solution is presented. Before that, a lemma is given first.
Lemma 3.5.2 There exist matrix Am×n = (aij) and vector b = [b1, b2, · · · , bm]T . Two
matrices A0 = [A 0]m×(n+1) and A = [A b]m×(n+1) are equivalent if and only if there
exists an unimodular matrix C with order n+ 1, such that A = A0C.
Proof The sufficiency is obvious. The necessity can be derived by the property that
elementary row and column operations do not change the rank of matrix. And the
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greatest common divisor of every k-th subdeterminant of two equivalent matrices is the
same.
Theorem 3.5.3 Linear equations AX = b, where A,X, b are integer matrices of size
m × n, n × 1 and m × 1, respectively, have integer solutions if and only if matrices A
and A = [A b] share the same set of invariant factors of the Smith normal form.
Proof Necessity: Suppose AX = b has integer solutions x = [x1, x2, · · · , xn]T . Multi-
ply the first n columns of A by −x1,−x2,· · · ,−xn, respectively, and add the products
to the (n+ 1)th column. Then, A0 is obtained. Consequently, A and A share the same
set of invariant factors.
Sufficiency: If A and A have the same invariant factors, so is for A0 and A. Therefore,
A is equivalent to A0. According to Lemma 3.5.2, there exists an unimodular matrix C
with order n+ 1, such that A = A0C.
Suppose the last column of C is Cn+1 = [c1, c2, · · · , cn, cn+1]T . The equations
ACn+1 = b hold. Equivalently, the equations AX = b have integer solutions.
By Theorem 3.5.3, it can be verified whether the given state equations of Petri net
have integer solutions. This theorem can be efficiently applied by taking advantages
of computational software. One limitation here is that the theorem only guarantees
the existence of integer solutions. Non-negativity cannot be addressed by this theorem.
More efforts are needed to completely solve this problem. However, it does provide an
efficient way to do the first test. If this test cannot pass, the candidate will be definitely
eliminated in the first round.
3.5.4 Approach by Integer Programming
Compared to the first approach, a more straightforward method is to solve the equations
numerically. Because one main concern in practice is to confine the whole experimental
procedure to be as simple and quick as possible, this concern can be formulated as
an integer programming problem [85]. The total number of reactions or efforts can
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be the objective function to be minimized, and the constrains are defined by the state




subject to CTx = 4M
x ∈ Z, x ≥ 0
In addition, in genetic regulatory networks, the markings of places usually take
binary values, i.e. 0 or 1. For instance, one gene is expressed high, which can be rep-
resented with “1” token in the corresponding place. Otherwise, it is represented with
“0” token. On the other hand, the transitions usually represent these occurrences of
reactions. Sometimes, to test the gene expression in terms of logical relations, some tran-
sitions are required to happen at most once, implying that the transforms are enabled
or disabled, as the reasoning process does. The above considerations can be categorized
as 0-1 integer programming or binary integer programming (BIP) where variables are
required to be only 0 or 1. Several supporting software can solve BIP problems. Among
them, LINDO is a powerful optimization tool for linear programming, integer program-
ming, etc. [60] We may use the built-in numerical algorithm to solve the state equations.
The solvability and non-negativity can be tested directly from the solutions.
3.5.5 Case Studies
In this part, two case studies will be presented to show applications of the aforementioned
methods. In the first example, one biochemical reaction network is built in Petri net.
Using Smith normal form test, one expected state is proven to be unreachable. The
second example is derived from the lac operon genetic regulatory network in E.coli.
The example will demonstrate the modification of model structure by binary integer
programming.
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Biochemical reactions
Suppose that there exist three molecules P1, P2 and P3. Three reactions can happen
among them. The detailed relations are illustrated below. The enzyme molecules are
omitted in the corresponding reactions.
Reaction 1: P2 → P1 + 4P3
Reaction 2: 2P3 + P2 → 2P1
Reaction 3: 3P1 → P2
The Petri net model is shown in Figure 3.8 .
Figure 3.8: Petri net representation of case study 1. The numbers on the arcs denote
the weights. Weights of 1 are omitted. Initial marking M0 is [4 4 4]
T .
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The initial markingM0 is [4 4 4]
T . The tokens can represent the numbers of molecules
or scaled concentrations. One expected result Md1 is [5 1 6]
T .
















Next, we will perform the Smith test to check whether this expected state can be
reached or not.
Smith normal form of CT1 is
CT1
∼= SNF1 = diag{1, 1, 8};
while, Smith normal form of [CT1 4M1] is
[CT1 4M1] ∼= SNF2 = [diag{1, 1, 2},03×1].
The invariant factors are different. According to Theorem 3.5.3, these state equa-
tions cannot have integer solutions. It can be concluded that the desired state of three
molecules cannot be realized. This conclusion can also be verified manually.
If the destination state is Md2 = [6 2 4]
T . Then, 4M2 = [2 − 2 0]T . Following the
same procedure as above, the Smith normal form of new augmented matrix [CT1 4M2]
is
[CT1 4M2] ∼= SNF3 = [diag{1, 1, 8},03×1].
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The same set of invariant factors guarantees the existence of integer solutions. And
the solutions are [x1 x2 x3]
T = [1 2 1]T , which represent after firing R1 and R3 once,
and firing R2 twice, the desired state can be obtained under the current initial marking.
However, the solutions of state equations cannot determine the firing sequences. This
drawback can be overcome by reachability graph complementarily provided that the
token distribution allows so.
Lac Operon pathway
This section demonstrates how we can use the integer programming to solve the state
equations, modify the undesired behaviour generated by the model and correct the
model structure accordingly. Biological facts used for constructing the model are from
the well-studied lac operon gene regulatory network happening in E.coli [2].
During the gene’s transcription, the activity of a single promoter can be controlled
by two different signals. The lac operon in E.coli, for example, is controlled by both
the lac repressor and the activator protein CAP. Glucose and lactose levels control the
initiation of the lac operon through their effects on the lac repressor protein and CAP.
Addition of lactose increases the concentration of allolactose which binds to the repressor
protein and removes it from the DNA. Addition of glucose decreases the concentration
of cyclic AMP (cAMP), then the dissociation of cAMP with CAP removes the activator
CAP from the DNA, which will lead to the shutdown of transcription. The transcripted
gene of lacZ, lacY and lacA will also join this regulatory network. In this work, we only
consider the initiation of the transcription under control of lactose and glucose.
It has been confirmed that, among four combinations of lactose and glucose, only
the first condition illustrated in Table 3.4 will turn on the transcription.
Based on the description above, the relations among components are established.
The first model is shown in Figure 3.9. Most places are the involved proteins, such as
lactose, glucose, etc. However, place P7 is used to represent the gene’s status “transcrip-
tion start”. Transition T1 indicates that the existence of lactose will lead to the gener-
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Table 3.4: Transcription on/off by combinations of lactose and glucose
condition lactose glucose transcription
1 + - yes
2 + + no
3 - - no
4 - + no
ation of allolactose. T6 has the similar purpose. The transitions, T2, T3, T4, T5, T7, T9,
which have only input arcs or output arcs are called sink transition or source transition,
respectively. As the name implies, source transition can only produce tokens. For exam-
ple, T3, T4, T5 will produce the repressor protein, CAP and cAMP, respectively. On the
other hand, sink transition will only consume tokens. For example, glucose will consume
cAMP by T7. T2 represents that allolactose will make the repressor malfunction. T9 is
denoting the suppression by “repressor”. Once T9 fires, it will consume “complex” on
the existence of “repressor”. Thus, T6 will be disabled, and transcription cannot start.
Figure 3.9: Petri net representation of Case study 2 Model 1
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As explained earlier, this problem can be formulated as binary integer program-
ming. The model should be tested by the four combinations in Table 3.4, which
correspond to four initial markings M10(P1, P2, · · · ) = [1 0 06]T , M20(P1, P2, · · · ) =
[1 1 06]
T , M30(P1, P2, · · · ) = [0 0 06]T , M40(P1, P2, · · · ) = [0 1 06]T . The final marking
is MF (P1, P2, · · · , P7, P8) = [06 1 0]T , in which the entry “1” at P7 position denotes the
initiation of transcription. Thus, there will be four state equations. If the state equa-
tions are expressed as ATx = b, then there will be four candidates of b. The incidence
matrix of A is as follows.
A9×8 =

−1 0 1 0 0 0 0 0
0 0 −1 −1 0 0 0 0
0 0 0 1 0 0 0 0
0 0 0 0 1 0 0 0
0 0 0 0 0 1 0 0
0 0 0 0 0 0 1 −1
0 −1 0 0 0 −1 0 0
0 0 0 0 −1 −1 0 1
0 0 0 −1 0 0 0 −1

Four candidates of b are
b1 = [ -1 0 0 0 0 0 1 0 ]
T ,
b2 = [ -1 -1 0 0 0 0 1 0 ]
T ,
b3 = [ 0 0 0 0 0 0 1 0 ]
T ,
b4 = [ 0 -1 0 0 0 0 1 0 ]
T .
By Smith normal form test, all four conditions have same invariant factors set,
implying that all four state equations have integer solutions. However, it is required
that all the values of markings are binary value, i.e. “0” or “1”. Therefore, Smith test
cannot help further. Binary integer programming is used to solve this problem. The
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subject to xi = {0, 1}
−x1 = α
−x7 = β
x1 − x2 = 0
−x2 + x3 − x9 = 0
x4 − x8 = 0
x5 − x7 − x8 = 0
x6 = 1
−x6 + x8 − x9 = 0
where {α, β} can be {−1, 0}, {−1,−1}, {0, 0} or {0,−1}.
Using LINDO, conditions 2 and 4 cannot find the solutions subject to binary values,
meaning that the initial markings under these two conditions cannot initiate the tran-
scription, which accords with the evidence. Condition 1 can find the solution, which
also coincides with the evidence that presence of lactose and absence of glucose initiate
the transcription. One unexpected result is case 3. It is also solvable subject to binary
value, and the solution is x = [ 0 0 0 1 1 1 0 1 0 ]
T .
Firing T4, T5, T6, T8 can also make the desired state reachable. This result contradicts
the evidence, and provides the warning of incorrectness of the model structure. After
check, the model cannot guarantee whenever “repressor” contains 1 token, it has to be
consumed by transition T9. So the model has to be modified accordingly.
In the new model shown in Figure 3.10, one intermediate place P9, “rep bar” is
added to indicate the status that the repressor is consumed by allolactose. This place
collaborates with “complex” to enable T6 and finally initiates the transcription.
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Figure 3.10: Petri net representation of Case study 2 Model 2
The incidence matrix becomes a 8× 9 matrix with the following form.
A8×9 =

−1 0 1 0 0 0 0 0 0
0 0 −1 −1 0 0 0 0 1
0 0 0 1 0 0 0 0 0
0 0 0 0 1 0 0 0 0
0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 1 −1 −1
0 −1 0 0 0 −1 0 0 0
0 0 0 0 −1 −1 0 1 0

The initial and final markings are similar with the previous model. The binary
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subject to xi = {0, 1}
−x1 = α
−x7 = β
x1 − x2 = 0
−x2 + x3 = 0
x4 − x8 = 0
x5 − x7 − x8 = 0
x6 = 1
−x6 + x8 = 0
x2 − x6 = 0
where {α, β} can be {−1, 0}, {−1,−1}, {0, 0}, or {0,−1}.
After performing the tests again, only condition 1 can be solved under current struc-
ture. This new model rules out other three impossible conditions. As concluded, this
modification improves the model’s reliability.
3.5.6 Discussion
In this section, through the analysis of solvability of state equations in terms of integer
non-negative solutions, we may eliminate impossible biological states and, furthermore,
check and improve the model structure. Two methods are proposed to solve Diophantine
equations both in theory and numerically, followed by applications on two examples.
One limitation is that we need the complete marking information, which is for large
systems often difficulty to specify. At this point, we will resort to model checking method
in next chapter.
The Smith normal form test needs further improvements to take care of non-negative
property. Moreover, as a necessary condition, solutions of state equations only provide
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the information of firing times, rather than the firing orders and the existence of fire
sequences. Although reachability graph does well at this aspect, it usually suffers from
the dimension explosion. As for the integer programming method, the capability to
perform this validation is smaller compared to model checking [25]. Many available
tools, such as PEP, PROD, INA, etc., have the interface to perform large scaled model
checking on Petri net model. So far, few studies have been done in the development of
tools for Petri net validation using linear programming. However, the success of integer
programming method will help to handle middle-scaled network efficiently. Therefore,
users can choose the appropriate method to do the validations.
3.6 Conclusion
In this chapter, we proposed two methods to address model validation issue. Both were
based on the state equations of Petri net.
In the first method part, it was demonstrated how apoptosis pathways modelled by
Petri nets can be analysed and validated using P-invariants, similar to how T-invariants
have been used to the same purpose in [38]. The structural requirements that the model
must have for P-invariants were also described. The results from P-invariant, which
agreed with the descriptions in the biological literature, proved the effectiveness of this
method.
In second part, reachability analysis based model validation problem was discussed.
Petri net was reused to model biological systems. An investigation on the existence
of non-negative integer solutions of state equations introduced a new angle to rule out
impossible biological states and further, check and improve the model structure. Two
approaches based on the Smith normal form test and integer programming , were pro-
posed to do the verifications and two subsequent case studies exemplified the successful
applications in biological systems.
In next chapter, model checking based method is fully developed to address the
target validation problem for microRNA. The method can be categorized into model
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validation problem as well. However, it is investigated from a totally different angle





The work in the previous two chapters lays the substantial foundations of our main
problem. In this chapter, we evaluate the regulatory roles of microRNAs by studying
the validation of repressive targets of microRNAs in the context of p53-dependent apop-
tosis pathway. Model checking based solution is developed and the experimentation is
designed for the wet lab verification as well.
4.1 Introduction
4.1.1 MicroRNA
Being first discovered in 1993 [53], microRNA, a sort of tiny pieces of RNA, has attracted
more and more scientists’ interests since then, due to the mystery of regulatory effect
in human cancer researches. MicroRNA (miRNA) refers to a large class of short length
(∼ 22 nucleotides) non-coding RNAs, which have negatively regulatory effects on the
expression of other genes. MiRNAs act as a subunit of RNA-induced silencing complex
(RISC), and specifically repress the target gene expression, through either direct cleavage
and degradation of the target messenger RNA (mRNA) or blockage of the target mRNA
translation process, by forming Watson-Crick base-pairings [111].
Mounting evidence shows that miRNAs are involved in many crucial biological pro-
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cesses, such as development, differentiation, apoptosis and proliferation, and their aber-
rant expression can manifest various growth abnormalities, including cancer. Recent
examination of miRNA expression profiles in tumour tissues has revealed that miRNA
expression is nearly ubiquitously deregulated in various types of human cancers, and is
found to have strong correlations with some known oncogenes and tumour suppressor
genes. In addition, miRNA expression patterns are highly specific for cell-type and cellu-
lar differentiation status, which actually can be used to classify poorly characterized hu-
man tumours. Furthermore, more than 50% of miRNAs are located in cancer-associated
genomic regions or in fragile sites. All these evidence suggests that miRNAs function
in concert with classical tumour suppressors and oncogenes to regulate key pathways
involved in cellular transformation and tumorigenesis. Therefore, a better understand-
ing of miRNA regulatory effects in genetic pathways involved in cancer development
should provide new and complementary insights into cancer pathogenesis, and should
contribute to the diagnosis and treatment of this group of diseases [9].
4.1.2 Target validation problem
MicroRNA and the other typical type of small RNA molecule—small interfering RNA
(siRNA)—usually participate into RNA interference (RNAi), which is a conserved bio-
logical mechanism for specific gene silencing [34]. This mechanism has been widely ex-
ploited in the fields, such as experimental biology, medicine, biotechnology, etc., among
which the most potential relies on the provision of novel therapeutic approaches for
caner treatment.
However, the target specificity of these two types of molecules is not often accurate
enough to perfectly base-wise pair with the target mRNA due to RNA’s structure. Com-
pared to siRNA, miRNA suffers more serious troubles in accurate target pairing. For
example, most of the animal miRNAs imperfectly complement the nucleotide pair; thus
the screening of the genome finds much more targets than the true number. With the
increase of evidence showing miRNAs’ aberration expressions in tumour cells, miRNA
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is considered to highly relate to carcinogenesis. The identification of miRNA repression
target becomes the central job to investigate its role as tumour suppressor or oncogene.
Several computational models are developed to do the target prediction. Despite the
variety of prediction algorithms, the common issue of those predictions is that the tools
return enormous number of targets so as to be considered that most of the results are
false positive [56]. Taking hsa-mir-34a for example. Pictar [50] predicts 354 targets;
TargetScan [56] gives 469 and the number from DIANA-microT V3.0 [63] is 575. There-
fore, it is a critical task to help to accurately determine the targets out of the prediction
pools.
4.1.3 Objective
However, it is hard to investigate the role of microRNA by itself; while it should be
involved in a specific biological environment. Recent five papers [13, 21, 36, 78, 95]
show the evidence connecting mir34a,b,c with p53 protein. P53 is considered as the
most important nexus in human cancers, evidenced by the fact that mutations of p53
are founded in nearly 50% of human cancers. On the other hand, apoptosis, also called
programmed cell death, effects highly the formation and death of tumor cells, in which
many critical components are the targets of p53. Thus, it is naturally proposed to learn
microRNA’s role in p53-dependent apoptosis pathway.
We propose to use systems biology approach which is a holistic investigation of the
dynamical behaviour of the biological pathways and utilize the properties to facilitate
the screening process. Different from the one-by-one proof done by the biologists, we
incorporate miRNA and its predicted targets into the context of certain pathways and
investigate the dynamical profiles and causality relationships among the components in
a batch mode. The basic idea goes as follows. We collect the real observed evidence
from the wet lab as the evaluation criteria. If the involvement of one predicted target
makes the pathways’ behaviour violate the evidence, we will cancel its candidature
provided that its absence leads to the agreement with the evidence, and vice versa. We
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may confirm the target by the agreement with the evidence when it is present and the
disagreement when it is absent.
To be more specific, we introduce the formal methods to accomplish this verification
process. Among the several approaches to formal methods, in this work, we concentrate
on the method of model checking due to the following two benefits [25]. First of all,
it is fully automated. The checking process is executed without man’s intervention.
Secondly, if the checking result is false, it will return one counterexample to demonstrate
the behaviour which falsifies the answer, which helps to locate the error source. We use
the primitive idea of model checking and compare the satisfaction results from the
models with and without considering miRNA inhibitions at the predicted places. Model
checking technique has already been successfully applied in many researches of systems
biology. For example, in the paper [10], model checking was introduced to validate the
qualitative model about the nutritional stress regulation network in E. coli. In another
work by [93], the authors used model checking to validate one model for B. subtilis
sporulation. In both papers, model checking is mainly in charge of model validation,
although a small portion of model predictions are suggested to be checked. In our work,
the main focus is about the post-modelling stage to do further analyses and predictions
on the models making full use of the power of model checking. To be further, we propose
the experiment design suggestions to assist the miRNA target validation in the wet lab.
This chapter is organized as follows. In Section 4.2, we give a brief introduction
of model checking technique, NuSMV model checker and the individual components,
such as model and specification, to be used in this chapter. In Section 4.3, we develop
our method in a problem-driven style and illustrate the whole procedure based on one
artificial example. We then apply the method to miRNA targeting problem and elabo-
rate the detailed checking results and possible experiment design schemes in Section 4.4.





Model checking, since firstly developed in the 1980s, has been widely used in the practical
hardware and software design [25]. The purpose of model checking is to check the
satisfaction of the desired property, technically called specification, by the considered
model. In this approach, specifications are expressed in a propositional temporal logic,
and circuit design and protocols are modelled as state-transition systems. An efficient
search procedure is used to determine if the specification is true for the transition system.
In other words, the transition system is checked to see whether it is a model of the
specifications.
There are a number of applications of model checking in systems biology. The works
differ in the modelling frameworks and studied topics [31]. The frameworks are of
qualitative or semi-quantitative type, such as boolean networks [82, 32], Petri nets [93],
state machine [3], etc. Some papers are used to demonstrate the functionality of model
checkers [3, 19]. Among the literatures, most of the work focuses on modelling and
analysis phases, where predictions are less made.
Compared to the old methods based on simulation and testing, model checking
exhaustively explores and checks the satisfaction on each individual reachable state,
avoiding the miss of any single behaviour. Several sophisticated techniques are also
developed to assist the expansion of reachability tree to prevent state explosion, such
ordered binary decision diagram (OBDD) [64], partial order reduction [25], unfolding
technique [65], etc.
4.2.2 Transition System
The “Model” in “Model checking” is always related to reactive systems. Such systems
may need to interact with the environment frequently. The state will represent an
instantaneous description of the system that captures the values of the variables at a
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particular instant of time. We also need to know the change of the state because of some
actions or events. We may use a pair of states, state before and state after the action
occurs, to determine the transition of the system. This kind of model is described by a
Kripke Structure.
Let AP be a set of atomic propositions. A Kripke structure M over AP is a four
tuple M = (S, S0, R, L) where
1. S is a finite set of states
2. S0 ⊆ S is the set of initial states
3. R ⊆ S×S is a transition relation that must be total, that is, for every state s ∈ S
there is a state s′ ∈ S, such that R(s, s′)
4. L : S → 2AP is a function that labels each state with the set of atomic propositions
true in that state
Thus, a path or a trajectory in the structure M initiated from a state s is an infinite
sequence of states pi = s0s1s2 . . . such that s0 = s and R(si, si+1)holds for all i ≥ 0.
Temporal logic has been proved to be useful for specifying concurrent systems, be-
cause they can describe the ordering of events in time without introducing time explicitly.
Therefore, it is used to describe the desired specifications or properties of the system.
It is often classified according to whether time is assumed to have a linear or branch-
ing structure, which correspond to linear temporal logic (LTL) and computational tree
logic (CTL), respectively. They could be translated from human languages following
the defined semantics.
4.2.3 Computational Tree Logic
Computational tree logic (CTL) is a branching-time logic, meaning that there are mul-
tiple options for the future state, which is non-determined. Therefore, there are many
different paths from the stating state to reach the final state. Biological reactions inter-
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leave to occur and there are non-deterministic choices for next state. Therefore, CTL is
one ideal option to describe the evidence abstracted from the real observations.
The following part is mainly focused on how to build a syntactically correct CTL
formulae and the interpretation of semantics.
Definition Let Φ be a set of atomic propositions. Then the following sentences are
formulae of CTL:
1. For all p ∈ Φ, p is a formula
2. True(>) and False(⊥)
3. Let φ be a formula, then ¬φ is a formula
4. Let φ1, φ2 be formulae, then (φ1∧φ2), (φ1∨φ2), (φ1 ⇒ φ2), (φ1 ≡ φ2) are formulae
5. Let φ, φ1, φ2 be a formula, then AXφ, EXφ, AFφ, EFφ, AGφ, EGφ, A[φ1Uφ2],
E[φ1Uφ2] are formulae.
The operators in the first four conditions are all traditional boolean logic operators,
negation(¬), disjunction(∨), conjunction(∧), implication(⇒), equivalence(≡).
The operators in the last condition are temporal operators, which are divided to the
following two categories.
1. Path quantifier A(All the paths), E(there Exists at least one path)
2. State operator X(neXt), G(Globally), F (Finally), U(Until)
In CTL, the temporal operators must consist of any one from each category and one
path quantifier must be followed by one state operator.
CTL formula is interpreted over transition systems in the structure of Kripke struc-
ture K = {S, S0, R, L}, with s ∈ S, φ ∈ F , where F is a set of well-defined formulae.
Then the semantics of these operators are defined as below:
• K, s |= true iff K, s 2 false
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• K, s |= p iff p ∈ L(s0)
• K, s |= ¬φ iff K, s 2 φ
• K, s |= φ1 ∧ φ2 iff K, s |= φ1 and K, s |= φ2
• K, s |= φ1 ∨ φ2 iff K, s |= φ1 or K, s |= φ2
• K, s |= φ1 ⇒ φ2 iff K, s 2 φ1 and K, s |= φ2
• K, s |= AXφ iff ∀〈s→ s1〉(K, s1 |= φ)
• K, s |= EXφ iff ∃〈s→ s1〉(K, s1 |= φ)
• K, s |= AGφ iff ∀〈s1 → s2 → · · · 〉(s = s1)∀i(K, si |= φ)
• K, s |= EGφ iff ∃〈s1 → s2 → · · · 〉(s = s1)∀i(K, si |= φ)
• K, s |= AFφ iff ∀〈s1 → s2 → · · · 〉(s = s1)∃i(K, si |= φ)
• K, s |= EFφ iff ∃〈s1 → s2 → · · · 〉(s = s1)∃i(K, si |= φ)
• K, s |= A[φ1Uφ2] iff ∀〈s1 → s2 → · · · 〉(s = s1)∃i((K, si |= φ2) ∧ (∀(j < i)K, sj |=
φ1))
• K, s |= E[φ1Uφ2] iff ∃〈s1 → s2 → · · · 〉(s = s1)∃i((K, si |= φ2) ∧ (∀(j < i)K, sj |=
φ1))
where K, s |= φ denotes “satisfaction relation” between a model K, one of its states s,
and a formula φ which holds if and only if the formula is true in that situation.
4.2.4 NuSMV
Many software tools are developed, which are providing fully automated approaches to
perform the checking tasks. Among them, NuSMV is a famous tool to perform the
checking task based on OBDD algorithm [24]. This tool provides a powerful checking
ability and the built-in script platform offers a flexible solution to program the model
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and specifications. Same as most model checkers, NuSMV also renders counterexample
when the desired property is rejected by the model. In addition, the easy accessibility
and configuration delight the using experience. Due to the above reasons, NuSMV is
selected to facilitate the verification task.
Table 4.1 lists the comparison with two other model checkers, which are also inves-
tigated during the tool-hunting stage.
Table 4.1: Model checker comparison
Name Formalism
LTL CTL
Cap C.E. Cap C.E.
Snoopy [80]
Charlie [26]







yes yes no no
NuSMV Built-in modelling language yes yes yes yes
“Cap” stands for capability; “C.E” stands for counter example.
The models used in the verification process adopt a high-level abstracted discrete
structure, usually in the form of automaton, Petri net, process algebra, etc. Petri net
owns the natural affinity to describe the biochemical substances and reactions in an intu-
itive pictorial format [22]. In this work, we represent the biological network in extended
Petri net, which includes the inhibition and read arc. Thus, activation, repression and
catalysis reactions happened in biochemical network could be all considered under this
framework. The places and the transitions in Petri net formalism stand for the biologi-
cal components and the reactions respectively, both of which are written in the NuSMV
build-in language. The detailed introduction of Petri net formalism could be referred to
Section3.2. The programming rules of reactions are briefly appended into Appendix A.
In addition, CTL is employed to describes the behaviours of biological systems in this
work. Therefore, CTL specifications are preferably derived to be checked by NuSMV.
The above descriptions could be summarised in the flowchart shown in Figure 4.1.
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Figure 4.1: Model checking flowchart used in this work
4.3 Method Illustration
In this section, we will illustrate the method by using one artificial example. The
illustration exemplifies the practical implementation and follows the problem-driven
style. Prior to that, we introduce the example setup first.
4.3.1 Pilot Example
This example mimics a small-scale biological network including the typical biochemical
reaction types. The structure is shown in Figure 4.2. In this example, it is assumed
that the predicted targets are P2, P4, P10 and P13. P2 is the false target and the rest
candidates are all true targets.
For the sake of convenience, three types of models are introduced herein. The same
definitions apply in the subsequent sections.
• “phenotype model” is used to depict the original network structure without con-
sidering the miRNA’s repression roles. The model shown in Figure 4.2 is the
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“phenotype model” for this example.
• “miRNA model” initially involves the connections from miRNA to all the possible
targets. As the check proceeds, this model updates step by step. If one target is
confirmed to be false, it will be dropped in the subsequent rounds. If the target is
confirmed to be true, it will be kept. Otherwise, the connections will be pending
until the evaluation criteria can conclude.
• “true model” reflects the real connections. It is introduced for two purposes. On
one hand, for illustration purpose, “true model” is used to generate the evaluation




















Figure 4.2: Prototype model of the pilot example. This model is built in Snoopy [80].
Circles represent places, and squares represent transitions. Grey places with the same
name represent the identical component. The place marked by one dot is expressed and
the corresponding state variable equals to 1. In this setup, it is assumed that P2 is the
false target and P4, P10, P13 are true targets. MiRNA is introduced to disable the
targets function by repression.
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Table 4.2: Evaluation criterion for individual target
Prototype miRNA Conclusion
model model
Case 1 agree disagree false target
Case 2 disagree agree true target
Case 3 agree agree not decided
Case 4 disagree disagree not decided
“agree” and “disagree” are with respect to the results given by true model.
4.3.2 Target Validation
In this part, we will illustrate how to use model checking based approach to predict
the targets validity and meanwhile how to effectively select the evidence to assist this
checking process.
Evaluation Criteria
The evidence generated from “true model” is considered to be the fact. The CTL
formulae converted from the evidence are evaluated by “prototype model” and “miRNA
model”. Four different cases arise. The comparisons and conclusions are summarized in
Table 4.2. The idea is intuitive. Only the one which agrees with the answer from the
true model will be considered to be correct. Case 1 and 2 can answer the correctness
directly. As for Case 3, we have to change to another evidence because that evidence
could not distinguish these two models. If Case 4 occurs, the improvement of prototype
model must be made. Moreover, the evidence mentioned here is specifically designed for
the individually investigated target, rather than general one for the whole set of targets.
Because the interplay among targets may influence the effectiveness of the evaluations.
The checking process is always stuck at certain critical positions in most cases. The
selection criteria for evidence are discussed in Section 4.3.2.
For the sake of carefulness, we herein conclude the target is true or false with high
possibility. The concern originates from the model’s correctness and evidence’s reliabil-
ity. First of all, all the components and connection information to build the model is
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from the biological discoveries. The information blast complexifies the modelling work.
Moreover, the debates about certain proteins and genes are always existing in the bi-
ology society. It is inevitable to have some uncertainties in the model. Therefore, the
model is only an abstraction of the reality. We pick the model which represents the
interested aspects. On the other hand, we collect the experimental evidences from the
reported data in the literature. Sometimes, the interpretation is not so strong as the
data indicate. Some results may be against with the ones in other experiments. Fur-
thermore, in most cases, the expected evidences are not always available. The evidence
retrieval brings about many troubles in systems biology research. Regarding this point,
we have a further discussion in Section 4.4. Due to these factors, based on currently
available resources we can only present our results reticently.
Selection Criteria of Specifications
To make the checking process effective, we must deliberately select the specifications
with respect to each target. Otherwise, the checking result could easily fall into Case 3
in Table 4.2.




First of all, we must evaluate the component dynamical type, namely global and
local types. Global components influence the whole dynamics seriously, such as P2, P11
in this example. Their positions usually lie on the main stream of the reaction chain.
The dysfunction of the global components will influence the main outcome. On the
other hand, local components influence the local dynamics and potentially cooperatively
influence the global dynamics, such as P4, P7, P13, etc. P13 influences P12 only and
P4 has the impact on its immediate downstream neighbour P5. If P4, P7 and P14
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are disabled simultaneously, the main stream will be blocked. Accordingly the global
dynamics will be influenced.
Secondly, we must consider the component position information. We generalized
into four position types—line type, collaborative type, feedback type and loop type.
The illustrations and respective examples could be found in Table 4.3. All the other
structures could be considered as the derivatives of the above four.
Thirdly, the query patterns summarize the translation rules from human descriptions
of biological behaviours to CTL formulae. In the work done in [67, 20], the authors
provided the detailed introductions and demonstrations. Here we re-summarize the
patterns in Table 4.4 specially for our own purposes from [67].
Checking Procedure
As introduced before, in this example, four targets are predicted. They are P2, P4, P10
and P13. The specifications are designed as shown in Table 4.5. As can be seen, the
specifications are specific for each candidate and meanwhile, the candidates are all of
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Table 4.4: Query pattern
Query pattern Human language description CTL formula
Occurrence It is possible for a state φ to occur EFφ
/Exclusion It is necessary for a state φ to occur AFφ
It is not possible for a state φ to occur !EFφ
Consequence If a state φ occur, then it is possibly fol-
lowed by a state ψ
AG(φ→ EFψ)
If a state φ occur, then it is necessarily
followed by a state ψ
AG(φ→ AFψ)
Sequence A state ψ is reachable and is possibly pre-
ceded at some time by a state φ
EF (φ&EFψ)
A state ψ is reachable and is possibly pre-
ceded all the time by a state ψ
EF (φUψ)
Invariance A state φ can persist indefinitely EGφ
A state φ must persist indefinitely AGφ
Repetitive A state φ will appear infinitely often AGAFφ
local type. Therefore, the update order will not affect the final result. However, if the
candidate is global, it will be prioritized to be the first.
Table 4.5: Checked formulae and results for pilot example
Target
CTL True Prototype miRNA
Formula model model model
P2 AGAF ( P1 = 1) T T F
P4 AG!( P5 = 1) T F T
P13 AG(( P12 = 1)→ AG( P12 = 1)) T F T
P10 EF ( P8 = 1&EF ( P7 = 1)) T T T
“T” for true, “F” for false
The formula designed for P2 is AGAF ( P1 = 1), which is interpreted as P1 will
infinitely often appears and the loop behaviour can persist. After checking results from
three models, “prototype model” which excludes the repression of miRNA on P2, gen-
erates the same answer with “true model”. The inclusion of this repression in “miRNA
model” violates the answer from “true model”. Moreover, the counterexample zeros in
on P2. Based on our evaluation criterion, P2 is confirmed as false target of miRNA and




The CTL formulae for P4 and P13 are designed as shown. The criterion tells that
both are true targets. These selected specifications effectively distinguish between pro-
totype model and miRNA model. However, if we choose the occurrence pattern formula
AF ( P12 = 1) to check P13, it will become less effective. P13 will influence the future
behaviour of P12 after P12 becomes active. However, AF ( P12 = 1) says P12 will even-
tually be active along all possible paths. It is not be able to handle the future behaviour
after P12 becomes active.
P10 is a local and feedback type component. Via P10, P8 could occur before P7,
against the main direction. If miRNA does not repress P10, this is true. Therefore, we
preferably select the sequence pattern formula
EF ( P8 = 1 & EF ( P7 = 1))
However, that formula is true under all three models, even in the case that the miRNA
repression is considered. The witness path shows
P1-t1-P2-t2-P6-t6-P7-t7-P8-t8-P9-t9-P11-t11
-P1-t1-P2-t2-P6-t6-P7.
P8 could occur in the first cycle, which appears prior to P7 in the next cycle. Under
such circumstance, our specification could not distinguish the results from “prototype
model” and “miRNA model”.
4.3.3 Experimental Design
As in the case of P10, in practice, we always encounter the similar problem of lacking
evidence for the check use. We have to shift our focus to design the experiment to
generate the useful evidence. This part addresses the issue that how we deliberately
design the experiment to generate useful evidence when it is lacking. The design scheme
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is proposed in terms of the experimental setup, initial conditions, observation points,
etc. The design in this example is the simplest case. In reality, several factors should
be involved, especially the technical feasibility. To avoid the occurrence of Case 4 in
Table 4.2, some general guideline to is suggested in Table 4.6.
Table 4.6: General guideline for experiment design
Type Query pattern Observation point
Global occurrence/exclusive any places
Line/collaborative consequence downstream of parallel place
Loop/feedback sequence the place in loop/feedback loop
Loop repetitive the place in loop
Regarding the problem in this example, we design as follows. We zoom in to only
consider the branching reactions starting from P6, ending at P9 shown in Figure 4.3.
P2 and P11 could be knocked out to construct this environment. In the current design,
the above formula could confirm that P10 is a true target.




Figure 4.3: Branching reactions
Up to here, we have finished the identification for all the candidates. P2 is removed
from the candidates list, and the other three are confirmed to be the true targets.
4.3.4 Model Modification
As mentioned before, the model is only an abstraction of the reality. Due to the current
limitations of techniques and experimentation conditions, the model has to tolerate
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uncertain and conflicting cases. Based on the available evidence, our methods could
give the answer to the candidates. It could be the case that the final verifications by
the biologists prove that the answer is wrong. Provided this new knowledge and the old
information, we have to update the model to correct the connections and re-evaluate
the roles of the components. The feedback from the biological society closes the loop
for systems biology research.
To accomplish this model modification step, we still utilize model checking facilities.
The idea is to use the counterexample to narrow down the searching range of error
source and propose possible solutions. Take P13 for example. Our prediction confirms
that P13 is the true target of miRNA. The real measurement tells that P13 is not the
target. We have to delete the repression connection from miRNA to P13, which turns
out to be the “prototype model”. The old evidence AG( P12 = 1 → AG( P12 = 1)
should be satisfied by “prototype model”, which originally disapprove that evidence.
The counterexample shows the path stops at the reaction t12, which means P13 will
consume P12 to falsify the formula. The possible modification could be that there exists
one missing component which has a higher priority to react with P13 than P12.
This problem always exists regardless of which formalism is chosen—continuous or
discrete. With the advent of new knowledge, the model is changing all the time. The
factors could be from the connections, parameters, components and even the principles.
Therefore, the instructions to modify the model have to be problem-dependent. Our
discussion here is providing one solution to identify the error source, and then propose
the suggestion accordingly.
4.4 Mir-34 Target Validation
4.4.1 Mir-34
MiRNA was firstly discovered to regulate the larval development timing in C. elegance
in 1993 [53]. Since then, more and more miRNAs have been identified and believed
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that they may influence nearly all aspects of health and disease. Among them, aber-
rant expression of mir-34a in neroblastoma draw much attention from the biology so-
ciety [103]. Especially, the correlation of mir-34a with the famous tumour suppressor
p53 protein attracted intensive studies on this small RNA. Recent studies reveal that
the expression of miR-34 family is robustly induced by DNA damage and oncogenic
stress in a p53-dependent manner [37]. In addition, inactivation of miR-34a strongly
attenuates p53-mediated apoptosis in cells exposed to genotoxic stress [78, 21]. Further
studies confirm that miR-34a are directly transactivated by p53 [36]. Taken together,
these findings strongly indicate that miR-34s can affect tumorigenesis in p53-dependent
apoptosis [39]. However, it is unclear whether miR-34s, especially miR-34a, are bona
fide tumour suppressors in their own right or just do fine-tuning of the gene expression
program initiated by p53. A critical step to answer this question is to identify the tar-
gets of miR-34s in the apoptosis pathway. However, the identification of true targets
represents a great challenge due to the current limitations of experimental techniques
and bioinformatics tools.
In this section, we will apply the aforementioned model checking based approach
to compensate the roles of biology and bioinformatics to facilitate the identification of
mir-34a’s true targets in apoptosis pathways.
4.4.2 Candidate Screening
As enumerated before, the listed computational tools render a great number of the
target predictions in the whole genome. However, the modelling of a complete system
is irrealizable and if possible, too complicated to do anything on it. Therefore, we
choose a middle-scale network to realize the functionality of our proposed method and
meanwhile, the chosen apoptosis pathway plays a significant role to regulate the cell
death for tumorigenesis study.
To make the predication pools as complete as possible, we use the results from
the database miRecords which fetch the enquiring results from 11 miRNA prediction
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programs [110]. The union number reaches 1116. We overlap with the components
in apoptosis pathways provided by KEGG pathway database [45] and finally narrow
down to 15 targets listed in Table 4.7 into our investigation range. The complete list
of predicted genes and the descriptions about the selected genes are summarized in
Appendix B.
4.4.3 Modelling and Validation
As introduced in Section 3.1.1, classical apoptosis pathways consist of extrinsic and in-
trinsic pathways. Extrinsic pathway is initiated by the ligation of the death receptors
by external ligand stimuli whereas intrinsic pathway is mitochondria-dependent stimu-
lated by non-receptor stimuli, such as DNA damage agents, oncogene stress, etc. Both
processes can trigger the caspase cascade activation. Two typical initiator caspases are
Caspase 8 and 9 in the extrinsic and intrinsic pathways respectively. p53’s activation
by the stimulating agents consequently transactivates some pro-apoptotic genes, BAX,
PUMA, FAS, etc., which are playing the main roles to determine the cell-fate [90],
and mir-34a as well. Anti-apoptotic proteins, such as FLIP, XIAP, BCL2, block the
death procedure by antagonizing the pro-apoptotic proteins. Besides the classical path-
ways, cell death is also regulated by survival factor withdrawal [55]. Therefore, survival
pathways should be taken into account in the whole picture as well. In the apoptosis
pathways we study presently, the survival pathways are mainly built around NF-κB
and PI3K-AKT/PKB [91, 98]. The former one is another transcription factor, which
can transactivate anti-apoptotic proteins XIAP, FLIP. The latter one is a kinase which
phosphorylates and deactivates pro-apoptotic proteins, such as BAD, Caspase 9. The
connection details could be found in the prototype model shown in Figure 4.4. The full
list of place names and the representative genes are listed in Appendix B.
Before we make use of this model, we should confirm its correctness. As done
in [10], we apply model checking technique to the prototype model to test the satisfaction
of some desired specifications under the conditions without the existence of mir-34a.
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Selected testing results are listed in Table 4.8. All the pro-apoptotic and anti-apoptotic
properties could be fulfilled under specified conditions. With the confidence on our
model, we proceed to the mir-34a’s target validation task.
4.4.4 Checking Results
Different from the pilot example in Section 4.3, we extract all evaluation specifications
from the experimental data. In most cases, mir-34a’s level is too low to exert any
biological functions [78]. Therefore, we have to consider two sources to get evidence.
One is from p53-initiated apoptosis. Elevated level of p53 can raise mir-34a’s repression
ability. The other one is by considering the experiment with ectopic expression of mir-
34a. To identify the role of mir-34a, the experiments usually introduce mir-34a from
external sources.
We select the following examples to illustrate the results by our approaches. The
summarized results could be found in Table 4.7.
Let us see the first candidate Caspase 8. In [12], it reported the occurrence of
Fas-induced extrinsic pathway in the p53-mediated apoptosis. Fas and p53 were both
activated, and accordingly mir-34a was active. Under this setup , Apoptosis occurred;
namely Caspase 3 was necessarily expressed. This phenomenon could be expressed in
CTL as follows.
AF ( CASP3 = 1) true
Caspase 8 is along the extrinsic pathway and has a direct impact on Caspase 3. There-
fore, this property is ideally for the purpose to check Caspase 8. The checking results are
listed in Table 4.7. The miRNA model which includes the repression of mir-34a on Cas-
pase 8 falsifies that formula, whereas the prototype model which excludes the repression
validates the description in the paper. Based on our criterion, Caspase 8 is concluded as
false target. So far, no biological study is conducted on this verification. However, we
may find the indirect data to prove our prediction from microarray dataset. Although
the method by observing microarray data will miss the bona fide miR-34a targets that
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are not affected at the level of mRNA abundance, successful identifications of miRNA
targets by this method have been accomplished by many groups [51, 58]. The dataset
GDS2755 from NCBI GEO [8] shows the gene expression data with overexpression of
mir-34a reported in [21] . We capture Caspase 8’ profile into Table 4.9. After statistical
analysis, Caspase 8 is not included in the differentially expressed gene list provided in
the supplementary material of [21]. The comparable levels of Caspase 8 indicate the
irrelevance to mir-34a overexpression. Therefore, it increases the confidence to rule out
the candidature of Caspase 8.
Next, let’s see the application on BCL2 which is an experimentally confirmed target.
Hence, our prediction should definitely agree with the existence of repression by mir-34a.
As reported in [78], mir-34a is a necessary condition for apoptosis. When we set all the
rest sufficient conditions satisfied, mir-34a becomes a necessary and sufficient condition
to let p53-dependent intrinsic pathway occur. The above formula AF ( CASP3 = 1)
still holds. Under this setting, we test the repression on BCL2. The prototype model
falsifies the formula and the miRNA model validates the formula. Therefore, BCL2 is
also confirmed to be the target of mir-34a by our approach.
Because of the intensive studies of classical p53-dependent apoptosis pathways, the
evidence about extrinsic and intrinsic pathways is abundantly found in the literature.
The direct success of applications is all from these categories. As seen in Figure 4.4,
most of the rest candidates reside in survival pathways. The correlations with p53 or
ectopic expressed mir-34a are rarely reported. Therefore, we have to consider the design
scheme to assist the validation task.
4.4.5 Design Schemes
The effective selection of evidence plays an important role to distinguish two types of
models and meanwhile the lack of evidence makes the trouble to conduct the verifica-
tion. Therefore, the design task is mainly about the specification. Based on the designed
specification, the experimental setup is thus prepared accordingly. For illustration pur-
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pose, the four generic structures in Table 4.2 cover all the possible cases in the graphs.
In reality, the situations are less complicated and share several common features of the
structure, such as locality, line type, sequence pattern, etc.
First of all, in this design work, initial condition must be the presence of p53 ac-
tivation or ectopic expression of mir-34a. The design guideline is as follows. If the
candidate is of line type, the specification could be designed to concern the impact on
its downstream neighbours in occurrence or sequence pattern. For example, to test
on IKK, NF-κB could be selected as evaluation point. AF ( NF-κ B = 1) is selected.
The observation in the experiment is on NFκB and to check whether its level will be
expressed or depressed. Similar strategies could be also applied to IL1RAP, MYD88,
PI3CD, etc. If the candidate is of collaborative type, the specification could be designed
to concern the impact on its collaborator or its repressed target in consequence pattern.
For example, XIAP deactivates Caspase 3 in a collaborative type. Caspase 3 could be
selected as evaluation point. AG(CASP3 = 1→ EF (CASP3 = 0)) is about the consis-
tent expression level of Caspase 3. If XIAP is not repressed by mir-34a, Caspase 3 will
not be consistently high level due to the blockage by XIAP.
Among the targets listed in Table 4.7, some candidates share the similar functions or
positions so as to be clustered as one type of component, such as BCL2 with BCL2L1,
PRKACB with PRKX. They cannot be distinguished in this macroscopic model in
terms of biological functions. Moreover, Caspase 7 is an equivalent executioner caspase
of Caspase 3. DFFA is the downstream of Caspase 3. Both are not involved in this
model. Experiment design scheme should be subject to the biological methods.
4.5 Conclusion
In this chapter, we have developed a systematic approach to filter the true targets of
miRNA from the enormous predictions made by the bioinformatics tools. We took full
advantage of model checking technique. Rather than confining to the model validation
issue, we further applied this technique to identify the target specificity by comparing the
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satisfaction results of real evidence between prototype model and miRNA model. The
shortlisted candidates could be provided to the biologists to conduct further verification
experiments. Thus, the biologists may focus more attentions on the highly possible ones
without wasting time on the targets with low possibilities. Meanwhile, this method could
handle a moderate number of identifications at the same time. Therefore, it potentially
provides a efficient and labour-saving facility for the miRNA study in the tumorigenesis.
When the application is impeded by the lack of real evidence, the generalized criteria
for specification selection are helpful to design the experiment to generate the desired
specifications. The drawback of these criteria is the difficulty for a non-expert to in-
terpret the temporal language and the assistance from the modeller is compulsory as
well. The proposed schemes in Table 4.7 are obtained under certain initial conditions































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.4: Prototype model of apoptosis pathways. Grey places with the same name
represent the identical component. The pathways are intertwined by the grey compo-
nents. The initial marking distributions may vary according to the investigated condi-
tions. The marking for each place is 1 which means the activation or the expression
level increase of that component, or 0 which means the deactivation or the expression
level decrease of that component. Transitions represent typical biochemical reactions,
such as activation, repression, phosphrylation, catalysis, combination, separation, etc.




Table 4.8: Approved specifications by the prototype model
Condition CTL Description
FAS ligation AF ( CASP3 = 1) Extrinsic apoptosis
AF ( CASP8 = 1) pathway is enabled
p53 and PUMA active AF ( CASP3 = 1) Intrinsic apoptosis
AF ( CASP9 = 1) pathway is enabled
IL1 active and intrisic EG( CASP3 = 0) Apoptosis can be disabled
or extrinsic open EG( CASP3 = 1→ by survival factor IL1
EF ( CASP3 = 0))
IGF active and intrisic EG( CASP3 = 0) Apoptosis can be disabled
or extrinsic open by growth factor IGF
Conditions on supportive components should be fulfilled accordingly.
Table 4.9: MicroArray dataset GDS2755
ID Identi- GSM GSM GSM GSM
REF fier 187633 187634 187631 187632
1553306 at CASP8 8.7 6.1 44.9 39.6
207686 s at CASP8 174.3 143.2 115.6 107.7
GSM187633: HCT116 cells with empty vector, technical replicate 1
GSM187634: HCT116 cells with empty vector, technical replicate 2
GSM187631: HCT116 cells with enforced miR-34a expression, technical replicate 1





Systems biology is an emerging area that attracts more and more attentions from vari-
ous disciplines. It originates from the problems from biologists and finally feedback the
solutions to the biology society. During the intermediate steps, the interactive collab-
orations happen frequently. Besides engineering approaches, the tools from computer
science, bioinformatics, statistics are essential as well. Prior to systems biology, bioin-
formatics has been proven very helpful to the biologists. The emergence of tools in
data mining, sequence analysis and protein structure modelling helps the biologists out
of the daily grind. However, nowadays we would like to learn more about the global
behaviours. The existing methods seem incompetent to accomplish this task. To break
the bottleneck, systems biology is a potential candidate. To substantiate this idea, in
this thesis, we proposed our solutions for microRNA target validation problem. During
the exploration, we reach our final goal step by step.
In Chapter 2, p53’s oscillatory behaviour was explained by one model in ordinary
differential equations. The relations among the components obeyed the basic biochem-
ical laws together with some reasonable approximations. The model was good enough
to reproduce the phenomena observed in the experiment. Furthermore, two new predic-
5.1 Contributions
tions were made from the mathematical model, which deserved a thorough investigation
of this well-established protein. One prediction was that a high level of stimulation
induced a dramatic change of the stability—from oscillation to steady state. The other
one was the frequency drift while changing the stimulation levels. No literature and
simulation work has reported these two phenomena so far. The verification experiment
could provide further evidence to mature the model.
In Chapter 3, we put p53 into a bigger context—apoptosis pathways. Identifying
a large number of parameters causes a serious trouble for modelling. Therefore, the
formalism was changed to be of discrete type, which thus skipped the hurdle of the
parameter identification for large-scale system. Under the discrete framework, the qual-
itative properties were emphasized, such as the existence of links, reaction types, the
expression occurrences, whereas the reaction rates, accurate expression levels were ne-
glected. Petri net was employed to describe the relations. To make a full use of the
model, it has to run the validation test. To address this issue, two methods were pro-
posed, i.e. invariant analysis and reachability analysis. Both methods were based on the
examination of the solutions of state equations. The illustrative examples showed the
convenience of these methods. The validation of p53-dependent apoptosis model paved
the way for next-step exploration.
In Chapter 4, the targets of microRNA were identified in the context of apoptosis
pathway. The bioinformatics tools provide a great number of candidates by sequence
matching, which makes the task of manual verification impossible. Our target is to sift
the highly possible targets from the predication pool. Model checking based approach
was developed. The results were obtained by comparisons among the different models
and the real evidence. The specifications were intentionally designed to effectively dis-
criminate the models. Moreover, when the desired evidence was lacking, we proposed
the experimental scheme by designing the specifications. In the case study, mir-34a
was taken as one example to illustrate this approach. Some results were verified by the
available findings. Some candidates were yet decided due to the lack of evidence and
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instead, the design schemes were provided for assistance. This chapter exemplified the
characteristics of interdisciplinary research which resorted to the various resources from
computer science, bioinformatics, biotechnology, systems engineering.
5.2 Future Work
Based on the considered issues in this thesis, some further work could be done to extend
the potential applications.
• It becomes more encouraging to draw attention from biologists to verify the pre-
dictions in our work. The hypotheses can be proven only by the support from
practical realization. The wet lab experiments will finally complete the loop and
provide the further knowledge to strengthen the models and methods. For exam-
ple, the desired experiments could be conducted to generate the specifications for
microRNA target validation. The p53 sampling guideline could facilitate the data
generation to polish our model. After several rounds, the models and methods
could become reliable to be fully utilized. In the meantime, the biologists will also
benefit from this.
• Regarding the continuous modelling, one possible direction is to build the model
to unify the conflicts in biological discoveries. In biological systems, there exist
several proteins or genes playing contradictory roles. In certain environment, it
performs conversely compared to other environment, even if its target gene or
binding site of DNA keep consistent. One possible explanation could be thought
as in different environments, different mechanisms of cell cycle or cell death are
triggered to decide the cell fates. Bifurcation analysis gives the direct clue for this
problem.
• Different mechanisms may generate the same phenomenon. For example, in p53-
Mdm2 modelling, each group has their own model. Which one is the closest to
the reality that is happening in cells? How could we differentiate these models?
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Hence, it is interesting to extract the characteristics of each type of modelling,
through which we may design the experiment to narrow down the differentiation
conditions. Consequently, we may introduce the modelling structure to other
biological systems which share the similar mechanisms.
• The strategy discussed for mir34a target validation in apoptosis pathways could be
promoted to other perspectives in terms of pathways and miRNAs. For example,
cell cycle pathway is of bigger size than apoptosis and more predicted candidates
are involved. Many cellular malfunctions are also related to the components in
cell cycle [17]. Other important miRNAs, such as mir-15/16, mir-127, etc., could
also be investigated with high interest [101]. Regarding the technical part, the
more quantitative model could be introduced to describe richer behaviours than
the qualitative one.
• Moreover, the most promising thing will be the development of a fully automated
checking program, which are fed by the information of connections and experimen-
tal evidence. The program can acquire the primary prediction results from the web
server, and then return the false and true targets for the chosen miRNA. The ap-
proach developed may finally evolve into a formal method to comprehensively and
rapidly identify targets genes for microRNAs. In addition, the successful accom-






All the transitions are defined in NuSMV script following the rules defined below. When
microRNA is included, the reaction is modified according to the repressive position. The
whole set of reactions shown in Figure 4.4 are listed in Table A.1. The descriptions of
biological functions are provided as well.
reaction#1#2[r#][i#](reactant variable list, product variable list,
catalyst variable list, inhibitor variable list)
--#1: number of reactants
--#2: number of products
--r#: catalyst participation and number of catalyst, by default 1
--i#: inhibitor participation and number of inhibitor, by default 1
Table A.1: Reaction List












t4 reaction20(Pro8, FLIP) Pro8 is consumed by FLIP
t5 reaction01r(CASP3,
CASP8)
generating CASP3 catalysed by CASP8
t6 reaction11r(BID, tBID,
CASP8)
generating tBID catalysed by CASP9
t7 reaction21i(tBID, BAX,
MITO, BCL2)














activating CASP3 by CASP9
t12 reaction20(XIAP, SMAC) SMAC is consumed by XIAP
t14 reaction20(XIAP, CASP3) CASP3 is consumed by XIAP
t15 reaction01r(BAX, p53) p53 transcriptionally activate BAX
t16 reaction01r(MIRNA, p53) p53 transcriptionally activate microRNA
t18 reaction11(XIAPtr, XIAP) translation of XIAP
m6 reaction11(TAK1, IKK) TAK1 phosphorylate IKK to active
m7 reaction20(IKK, IkB) IKK consume IkB
103
Table A.1: (Continued)
# Reaction type Biological function
m8 reaction11i(NFkBi, NFkB,
IkB)
generating NFkB, inhibited by IkB
m9 reaction12(NFkB, XIAPtr,
FLIP)

















IKK is phosphorylted by AktPKB
s4 reaction20i(BAD, BCL2,
AktPKB)
AktPKB disable the consumption of
BCL2 by BAD by phosphorylation
s5 reaction10r(CASP9, Ak-
tPKB)
AktPKB disable CASP9 by phosphoryla-
tion
n1 reaction11(IL3, cAMP) cAMP is activated by IL3
n2 reaction11(cAMP,PKA) PKA is activated by cAMP
n3 reaction11(PKA, Ak-
tPKB)
PKA phosphorylate AktPKB to active
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Appendix B
Gene Names in Apoptosis Model
All the genes are from the genome of Homo sapiens (human). For certain genes, one
representative of the homologs is shown. Regarding the places which correspond to the
organelle and complex, the gene information is not applicable. All the gene information
is retrieved from NCBI Entrez Gene [69].
Table B.1: Gene Name List
Place Name Official Symbol Gene Name Gene ID
MIRNA MIR34A microRNA 34a 407040
FASL FASLG Fas ligand (TNF superfamily, mem-
ber 6)
356
FAS FAS FAS(TNF receptor, member 6) 355
FASC n.a FASL-FAS Complex n.a
FADD FADD Fas (TNFRSF6) -associated via
death domain
8772
DISC n.a. Death-inducing signaling complex n.a
Pro8 n.a procaspase-8 n.a.




Place Name Official Symbol Gene Name Gene ID
CASP8 CASP8 caspase 8, apoptosis-related cys-
teine peptidase
841
CASP3 CASP3 caspase 3, apoptosis-related cys-
teine peptidase
836
BID BID BH3 interacting domain death ago-
nist
637
tBID n.a truncated BID n.a
p53 TP53 tumour protein p53 7157
BAX BAX BCL2-associated X protein 581
PUMA BBC3 BCL2 binding component 3 27113
BCL2 BCL2 B-cell CLL/lymphoma 2 596
MITO n.a mitochondria n.a
CYTOC CYCS cytochrome c, somatic 54205
SMAC DIABLO diablo homolog (Drosophila) 56616
APAF APAF1 apoptotic peptidase activating fac-
tor 1
317
CASP9 CASP9 caspase 9, apoptosis-related cys-
teine peptidase
842
CASP3 CASP3 caspase 3, apoptosis-related cys-
teine peptidase
836
XIAP XIAP X-linked inhibitor of apoptosis 331
IL1 IL1 interleukin 1 3551
IL1R IL1R1 interleukin 1 receptor, type I 3554
ILC n.a IL1-IL1R complex n.a
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Table B.1: (Continued)
Place Name Official Symbol Gene Name Gene ID
MyD88(IRAK) MYD88 myeloid differentiation primary re-
sponse gene (88)
4615
(MyD88)IRAK IRAK1 interleukin-1 receptor-associated ki-
nase 1
3654
TRAF6 TRAF6 TNF receptor-associated factor 6 7189
TAK1 MAP3K7 mitogen-activated protein kinase ki-
nase kinase 7
6885
IKK CHUK conserved helix-loop-helix ubiqui-
tous kinase
1147
IkB NFKBIA nuclear factor of kappa light
polypeptide gene enhancer in
B-cells inhibitor, alpha
4792
NFkBi n.a NFκB initiation n.a
NFkB NFKB1 nuclear factor of kappa light
polypeptide gene enhancer in
B-cells 1
4790
XIAPtr n.a XIAP transcript n.a.
IGF IGF1R insulin-like growth factor 1 receptor 3480
TrkA NTRK1 neurotrophic tyrosine kinase, recep-
tor, type 1
4914
PI3K PIK3CA phosphoinositide-3-kinase, cat-
alytic, alpha polypeptide
5290
PTEN PTEN phosphatase and tensin homolog 5728





Place Name Official Symbol Gene Name Gene ID
BAD BAD BCL2-associated agonist of cell
death
572
IL3 IL3 interleukin 3 (colony-stimulating
factor, multiple)
3562
cAMP CAMP cathelicidin antimicrobial peptide 820






As shown in the Figure 1.1, the starting point where we conduct our research is the
demands from biology society. Moreover, our modelling and verification must be tested
by the data from the biological experiments as well. Therefore, the understanding of
the basic biological concepts and the underlying principles become essential. As long as
we know their language, we can communicate well with the biologists and elucidate our
results in a more meaningful and practical way.
The interpretation of the biological data plays the same important role to systems
biology research. No matter where the data comes from, either from direct feed by
collaborators or the reports in the literature, the collected data is directly translated for
modelling and analysis. Therefore, it is another essential task to get familiar with the
experimental methods and the data representations.
In this appendix, the elementary knowledge about biological systems is included in
the first half and then the brief survey about some most common experimental tools is
given. Those materials provide the background information for the work we undertake.
C.1 Elementary Molecular Biology
C.1 Elementary Molecular Biology
There exist various kinds of living things in the world. For example, animals, fungi, bac-
teria. There are also non-living matter, such as water, rock, etc. [2] How to characterize
living things and distinguish them from the non-living matter?
Cell All living things are made of cells: small, membrane-enclosed units filled with a
concentrated aqueous solution of chemicals and endowed with the extraordinary ability
to create copies of themselves by growing and dividing in two. Typically, there are
two kinds of cells, say eucaryotic cell and procaryotic cell. The critical difference is the
ownership of nucleus or not. For eucaryote, living organism are composed of one or
more cells with a distinct nucleus and cytoplasm, including all forms of life except viruses
and bacteria. Contrarily, procaryote is a major category of living cells distinguished
by the absence of a nucleus.
Figure C.1: Cell contents [2]
Besides nucleus, some other organelles are also enclosed in the cell, referring to
Figure C.1. For example, mitochondria, chloroplast, ribosomes, etc. They all perform
the functional roles in corresponding sub-environment. Nucleus is the information store
of the cell. Mitochondria generates energy from food to power the cell. Ribosome helps
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in the translation process of protein. Chloroplasts, which are found only in plants and
algae, capture energy from sunlight. As for the structure difference between plants and
animals, eucaryotes and procaryotes, it will not be mentioned much in this part. What
concern us most is the activities happened in the nucleus of eucaryotic cells.
Nucleus The nucleus is usually the most prominent organelle in a eucaryotic cell. It
is enclosed within two concentric membranes that form the nuclear envelope, and it
contains molecules of DNA—extremely long polymers—that encode the genetic infor-
mation of the organism. DNA also stores the genetic information in procaryotic cells;
these cells lack a distinct nucleus not because they lack DNA, but because they do not
keep it inside a nuclear envelope, segregated from the rest of the cell contents.
DNA The development of molecular biology is synchronized with the DNA’s recog-
nition and exploration. DNA is a store of genetic codes controlling and regulating the
synthesis and functioning of proteins and other molecules. The term “DNA” is short for
deoxyribonucleic acid. It is a macromolecule which is composed of large number of nu-
cleotides, and is packaged into individual chromosomes. The most attractive feature is
the double helix structure of DNA, which was determined by James Watson and Francis
Crick in 1953.
“Today, the fact that DNA is the genetic material is so fundamental to bi-
ological thought that is difficult to appreciate what an enormous intellectual
gap this discovery filled.” by Bruce Alberts, et al. [2]
Nucleotide has three parts: a nitrogen-containing base; a pentose(a sugar molecule
containing 5 carbon atoms); one or more phosphate groups. According to the dif-
ferent bases of nucleotides, we will have two categories and totally five members, i.e.
pyrimidines have uracil(U), cytosine(C), thymine(T); while purines have adenine(A) and
guanine(G). The different combinations of bases represent different genetic information.
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RNA(ribonucleic acid) is a similar molecule with DNA. The difference resides in
the following three aspects. The sugar contained in RNA’s nucleotide is ribose, not
the deoxyed form. And what’s more, RNA contains the bases A, C, G, U, while DNA
contains A, C, G, T. Finally, RNA is in a single-stranded form, and DNA typically
exists in the double-stranded form—two single strands of DNA—running anti-parallel
and joined by base-base hydrogen bonds: A with T, G with C.
Protein Proteins consist of one or more polypeptides. A polypeptide consist of a cova-
lently linked long chain of amino acids. There are found totally 20 kinds of amino acids
in nature. The order of amino acid constituting polypeptide is coded by genetic informa-
tion stored in the DNA molecules. From DNA’s base combinations to protein’s amino
acid sequences, thus enabling the cell to perform various functions, it is a complicated
process, which is known as “Central Dogma of Molecular Biology”.
Central Dogma of Molecular Biology This dogma implies the process from DNA
to RNA to protein. It contains mainly three major stages (shown in Figure C.2), which
are all accomplished with the assistance of enzymes and co-factor proteins:
1. Replication of DNA
2. Transcription of RNA and processing to yield mRNA which migrate to the cyto-
plasm
3. Translation by ribosomes of the code carried by mRNA into proteins
Gene expression Gene is a unit of heredity composed of DNA. It occupies a specific
position on a chromosome. It concerns with a specific function, such as synthesis of a
protein or an mRNA. Besides the coding sequences, regulatory gene sequences(known
as operons) adjacent to the gene contains information about when and in which cell
type the gene is to be expressed. Therefore, in process of expression, many enzymes
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Figure C.2: Central Dogma of Molecular Biology [2]
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and RNAs are involved to control the replication, transcription and translation, finally,
determine the gene expression levels.
Pathways Biological systems consist of respiratory system, circulatory system, im-
mune system, reproductive system, etc. The pathways underlying in these systems can
be categorized into three-fold: metabolic pathways, signalling transduction pathways
and gene regulatory networks. Gene regulatory network has been introduced before. It
concerns about the positive or negative control and regulation of gene expression level by
the components included. Metabolic pathways study the energy acquirement or loss and
the transfer of energy among biochemical reactions. Signalling transduction pathways
include the intra- and inter- cellular interactions among molecules, proteins, organelles
and so on. The external stimuli are also necessary to be considered. All these networks
must be modelled appropriately and then employed to explore more.
C.2 Experimental Methods
In this part, the one-sentence version of explanations could facilitate the understanding
of the aims of frequently-encountered methods, and the principles behind those methods
are omitted. Because the current measuring technology is not able to reflect the real ac-
curate levels in the molecular biology laboratories. In most cases, the data at molecular
scale is more qualitative. For example, in northern blot result, the levels are indicated
by the grey density through which only high and low indices are obtained. PCR tech-
niques are used to amplify the DNA samples; blotting methods are used to detect and
measure the expressed level of DNA sequence, RNA and protein. DNA microarray is
a high-throughput measurement of genome-scale RNA expression. Flow cytometry and
luciferase are for a relative macroscopic purpose. The following information is collected
from Wikipedia [104] key words search.
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PCR In molecular biology, the polymerase chain reaction (PCR) is a technique to
amplify a single or few copies of a piece of DNA across several orders of magnitude,
generating thousands to millions of copies of a particular DNA sequence.
RT-PCR Reverse transcription polymerase chain reaction (RT-PCR) is a variant of
polymerase chain reaction (PCR), a laboratory technique commonly used in molecular
biology to generate many copies of a DNA sequence, a process termed “amplification”.
Reverse transcription PCR is not to be confused with real-time polymerase chain reac-
tion (Q-PCR/qRT-PCR), which is also sometimes (incorrectly) abbreviated as RT-PCR.
Real-time PCR In molecular biology, real-time polymerase chain reaction, also called
quantitative real time polymerase chain reaction (Q-PCR/qPCR) or kinetic polymerase
chain reaction, is a laboratory technique based on the PCR, which is used to amplify
and simultaneously quantify a targeted DNA molecule. It enables both detection and
quantification (as absolute number of copies or relative amount when normalized to
DNA input or additional normalizing genes) of one or more specific sequences in a DNA
sample.
Southern Blot A southern blot is a method routinely used in molecular biology for
detection of a specific DNA sequence in DNA samples.
Northern Blot The northern blot is a technique used in molecular biology research
to study gene expression by detection of RNA (or isolated mRNA) in a sample.
Western Blot The western blot (alternatively, protein immunoblot) is an analytical
technique used to detect specific proteins in a given sample of tissue homogenate or
extract.
DNA Microarray DNA Microarray can be used to detect DNA (as in comparative
genomic hybridization), or detect RNA (most commonly as cDNA after reverse tran-
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scription) that may or may not be translated into proteins. The process of measuring
gene expression via cDNA is called expression analysis or expression profiling.
Flow cytometry Flow cytometry is a technique for counting and examining micro-
scopic particles, such as cells and chromosomes, by suspending them in a stream of fluid
and passing them by an electronic detection apparatus. It allows simultaneous multi-
parametric analysis of the physical and/or chemical characteristics of up to thousands
of particles per second. Flow cytometry is routinely used in the diagnosis of health
disorders, especially blood cancers, but has many other applications in both research
and clinical practice.
Luciferase Luciferase is a generic term for the class of oxidative enzymes used in
bioluminescence and is distinct from a photoprotein. One famous example is the firefly
luciferase (EC 1.13.12.7) from the firefly Photinus pyralis.
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